Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
13 "Yong-ho Lee"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Diabetes, obesity and metabolism
Prevalence of Mortality and Vascular Complications in Older Patients with Diabetes in Korea
Kwang Joon Kim, Jeongmin Lee, Yang Sun Park, Yong-ho Lee, Kyeong Hye Park, Hee-Won Jung, Chang Oh Kim, Man Young Park, Hun-Sung Kim, Bong-Soo Cha
Endocrinol Metab. 2025;40(3):448-458.   Published online February 18, 2025
DOI: https://doi.org/10.3803/EnM.2024.2173
  • 3,761 View
  • 94 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the prevalence of diabetes mellitus (DM) and impaired fasting glucose, as well as their management and comorbidities among older Korean adults.
Methods
Data from 269,447 individuals aged 65 years and older from the Korean National Health Insurance Service between 2000 and 2019 were analyzed to evaluate trends in DM prevalence, healthcare utilization, mortality, and complications.
Results
Among 269,447 individuals, 18.6% (n=50,159/269,447) were diagnosed with DM and 27.0% (n=72,670/269,447) had impaired fasting glucose. The DM group had the highest body mass index, waist circumference, and prevalence of current smokers (P<0.001) but not the highest hypertension prevalence. From 2010 to 2019, the prevalence of DM and impaired fasting glucose increased from 15.5% to 21.9% and from 26.0% to 30.6%, respectively. Cancer-related mortality in DM was 1.15 times higher than in those with normal glucose tolerance (P<0.001), and cardiovascular disease-related mortality was 1.32 times higher (P<0.001); all mortalities were higher in female participants. Myocardial infarction (hazard ratio [HR], 1.34; P<0.001), stroke (HR, 1.24; P<0.001), and heart failure (HR, 1.13; P<0.001) were significantly higher in those with DM.
Conclusion
This is the first study to investigate the prevalence of DM and related complications in older individuals based on longterm representative data in Korea. These results highlight the necessity for targeted interventions to enhance management and outcomes in this population.

Citations

Citations to this article as recorded by  
  • Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)
    Sangmo Hong, Won J. Kim, Sungrae Kim, Jung H. Park, Eun S. Kang, Min K. Moon, Jae T. Kim, Ji‐Oh Mok, Ki Y. Lee, Cheol‐Young Park, Chang B. Lee
    Diabetes, Obesity and Metabolism.2026; 28(2): 906.     CrossRef
Close layer
Miscellaneous
Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
Ji Young Lee, Minyoung Lee, Dong-Hee Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
Endocrinol Metab. 2022;37(4):684-697.   Published online August 29, 2022
DOI: https://doi.org/10.3803/EnM.2022.1446
  • 8,417 View
  • 195 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Muscle atrophy is caused by an imbalance between muscle growth and wasting. Delta-like 1 homolog (DLK1), a protein that modulates adipogenesis and muscle development, is a crucial regulator of myogenic programming. Thus, we investigated the effect of exogenous DLK1 on muscular atrophy.
Methods
We used muscular atrophy mouse model induced by dexamethasone (Dex). The mice were randomly divided into three groups: (1) control group, (2) Dex-induced muscle atrophy group, and (3) Dex-induced muscle atrophy group treated with DLK1. The effects of DLK1 were also investigated in an in vitro model using C2C12 myotubes.
Results
Dex-induced muscular atrophy in mice was associated with increased expression of muscle atrophy markers and decreased expression of muscle differentiation markers, while DLK1 treatment attenuated these degenerative changes together with reduced expression of the muscle growth inhibitor, myostatin. In addition, electron microscopy revealed that DLK1 treatment improved mitochondrial dynamics in the Dex-induced atrophy model. In the in vitro model of muscle atrophy, normalized expression of muscle differentiation markers by DLK1 treatment was mitigated by myostatin knockdown, implying that DLK1 attenuates muscle atrophy through the myostatin pathway.
Conclusion
DLK1 treatment inhibited muscular atrophy by suppressing myostatin-driven signaling and improving mitochondrial biogenesis. Thus, DLK1 might be a promising candidate to treat sarcopenia, characterized by muscle atrophy and degeneration.

Citations

Citations to this article as recorded by  
  • Advancements in the study of DLK1 in the pathogenesis of diabetes
    Min Li, Yanqiu Peng, Yuke Shi, Yunfei Liu, Jian Zhang
    Life Sciences.2025; 369: 123535.     CrossRef
  • Molecular mechanism of Activin receptor inhibition by DLK1
    Daniel Antfolk, Qianqian Ming, Anna Manturova, Erich J. Goebel, Thomas B. Thompson, Vincent C. Luca
    Nature Communications.2025;[Epub]     CrossRef
Close layer
Review Article
Diabetes, Obesity and Metabolism
State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
Yongin Cho, Yong-ho Lee
Endocrinol Metab. 2022;37(1):38-52.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2022.102
  • 9,264 View
  • 310 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, and non-alcoholic steatohepatitis (NASH), a subtype of NAFLD, can progress to cirrhosis, hepatocellular carcinoma, and death. Nevertheless, the current treatment for NAFLD/NASH is limited to lifestyle modifications, and no drugs are currently officially approved as treatments for NASH. Many global pharmaceutical companies are pursuing the development of medications for the treatment of NASH, and results from phase 2 and 3 clinical trials have been published in recent years. Here, we review data from these recent clinical trials and reports on the efficacy of newly developed antidiabetic drugs in NASH treatment.

Citations

Citations to this article as recorded by  
  • Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease
    Eugene Han, Sin Yung Woo, Justin Y. Jeon, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee, Yong-ho Lee
    Diabetes Research and Clinical Practice.2025; 224: 112209.     CrossRef
  • Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    BMJ.2024; 384: e076388.     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Soyeon Shin, Jaeyoung Kim, Ju Yeon Lee, Jun Kim, Chang-Myung Oh
    Journal of Obesity & Metabolic Syndrome.2023; 32(4): 289.     CrossRef
  • Sodium-glucose cotransporter 2 inhibitors for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A nationwide propensity-score matched cohort study
    Jinyoung Kim, Kyungdo Han, Bongsung Kim, Ki-Hyun Baek, Ki-Ho Song, Mee Kyoung Kim, Hyuk-Sang Kwon
    Diabetes Research and Clinical Practice.2022; 194: 110187.     CrossRef
Close layer
Original Articles
Diabetes, Obesity and Metabolism
The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
Hyun Min Kim, Yong-ho Lee
Endocrinol Metab. 2021;36(6):1232-1242.   Published online November 23, 2021
DOI: https://doi.org/10.3803/EnM.2021.1087
  • 8,079 View
  • 164 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The prevalence of non-alcoholic fatty liver disease (NAFLD) has rapidly increased worldwide. The aim of this study was to investigate whether there is an independent relationship between regional fat distribution, especially leg fat mass, and the presence of NAFLD using nationally representative data in Korea.
Methods
This cross-sectional study analyzed data from 14,502 participants in the Korea National Health and Nutrition Examination Survey 2008 to 2011. Total fat mass, leg fat mass, and appendicular skeletal muscle mass were measured by dual-energy X-ray absorptiometry. Validated NAFLD prediction models and scoring systems for hepatic fibrosis were used.
Results
The leg fat to total fat (LF/TF) ratio showed a negative relationship with many factors, including body mass index, waist circumference, blood pressure, fasting blood glucose, and liver enzyme levels. When the LF/TF ratio and indices of hepatic steatosis were stratified by quartiles, the LF/TF ratio showed a negative correlation with the scoring systems that were used. The LF/TF ratio showed better accuracy in predicting NAFLD than total fat mass or leg fat mass alone. After adjusting for various traditional and lifestyle factors, a low LF/TF ratio remained a risk factor for NAFLD. Among NAFLD subjects, the LF/TF ratio showed a negative relationship with hepatic fibrosis.
Conclusion
A lower LF/TF ratio was markedly associated with a higher risk of hepatic steatosis and advanced hepatic fibrosis using various predictive models in a Korean population. Therefore, the LF/TF ratio could be a useful anthropometric parameter to predict NAFLD or advanced hepatic fibrosis.

Citations

Citations to this article as recorded by  
  • Low leg fat mass is associated with low insulin sensitivity, inflammatory markers, and β-cell dysfunction in non-obese Japanese people
    Satomi Minato-Inokawa, Mari Honda, Ayaka Tsuboi-Kaji, Mika Takeuchi, Kaori Kitaoka, Miki Kurata, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo
    Scientific Reports.2025;[Epub]     CrossRef
  • Body composition mediates the association between fatty acids and NAFLD risk: a prospective cohort study
    Qishan Yang, Xinming Xu, Yue Chen, Zhicheng Zhang, Berty Ruping Song, Liang Sun, Xiang Gao
    Journal of Health, Population and Nutrition.2025;[Epub]     CrossRef
  • Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up
    Xiaoyan Hao, Honghai He, Liyuan Tao, Wei Zhao, Peng Wang
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Asieh Mansour, Saeed Pourhassan, Hadis Gerami, Mohammad Reza Mohajeri‐Tehrani, Marziye Salahshour, Ali Abbasi, Elham Madreseh, Sayed Mahmoud Sajjadi‐Jazi
    Obesity Science & Practice.2024;[Epub]     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Adipose tissue insulin resistance index was inversely associated with gluteofemoral fat and skeletal muscle mass in Japanese women
    Satomi Minato-Inokawa, Mari Honda, Ayaka Tsuboi-Kaji, Mika Takeuchi, Kaori Kitaoka, Miki Kurata, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo
    Scientific Reports.2024;[Epub]     CrossRef
  • A greater ratio of thigh subcutaneous fat to abdominal fat is associated with protection against non-alcoholic fatty liver disease
    Yebei Liang, Peizhu Chen, Siyu Chen, Dan Liu, Fusong Jiang, Zhijun Zhu, Keqing Dong, Li Wei, Xuhong Hou
    JHEP Reports.2023; 5(7): 100730.     CrossRef
  • Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019–2021
    Dae Eon Kang, Si Nae Oh
    Nutrients.2023; 15(18): 3901.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
Endocrinol Metab. 2021;36(4):823-834.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1074
  • 9,162 View
  • 166 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. Type 2 diabetes mellitus (T2DM) is a risk factor that accelerates NAFLD progression, leading to fibrosis and cirrhosis. Thus, here we aimed to develop a simple model to predict the presence of NAFLD based on clinical parameters of patients with T2DM.
Methods
A total of 698 patients with T2DM who visited five medical centers were included. NAFLD was evaluated using transient elastography. Univariate logistic regression analyses were performed to identify potential contributors to NAFLD, followed by multivariable logistic regression analyses to create the final prediction model for NAFLD.
Results
Two NAFLD prediction models were developed, with and without serum biomarker use. The non-laboratory model comprised six variables: age, sex, waist circumference, body mass index (BMI), dyslipidemia, and smoking status. For a cutoff value of ≥60, the prediction accuracy was 0.780 (95% confidence interval [CI], 0.743 to 0.817). The second comprehensive model showed an improved discrimination ability of up to 0.815 (95% CI, 0.782 to 0.847) and comprised seven variables: age, sex, waist circumference, BMI, glycated hemoglobin, triglyceride, and alanine aminotransferase to aspartate aminotransferase ratio. Our non-laboratory model showed non-inferiority in the prediction of NAFLD versus previously established models, including serum parameters.
Conclusion
The new models are simple and user-friendly screening methods that can identify individuals with T2DM who are at high-risk for NAFLD. Additional studies are warranted to validate these new models as useful predictive tools for NAFLD in clinical practice.

Citations

Citations to this article as recorded by  
  • An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
    Zhuolin Zhou, Nan Gao, Jiaojiao Liu, Xuerong Ma, Zhijuan Ge, Cheng Ji
    Diabetes, Obesity and Metabolism.2026; 28(1): 122.     CrossRef
  • Prevalence, Sonographic Characteristics, and Metabolic Predictors of Nonalcoholic Fatty Liver Disease in Adults With Type 2 Diabetes in Tanzania
    Zubeir Zubeir, Zuhura Nkrumbih, Salama Ally, Yasser H. Hadi
    Dr. Sulaiman Al Habib Medical Journal.2025; 7(3): 180.     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
    Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
    Biomedicines.2023; 11(4): 1097.     CrossRef
Close layer
Clinical Study
Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
Da Hea Seo, Shinae Kang, Yong-ho Lee, Jung Yoon Ha, Jong Suk Park, Byoung-Wan Lee, Eun Seok Kang, Chul Woo Ahn, Bong-Soo Cha
Endocrinol Metab. 2019;34(3):282-290.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.282
  • 9,111 View
  • 102 Download
  • 18 Web of Science
  • 20 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

This study investigated the overall status of diabetes control and screening for diabetic microvascular complications in patients with type 2 diabetes mellitus attending primary care clinics in Korea.

Methods

In this cross-sectional observational study, 191 primary care clinics were randomly selected across Korea from 2015 to 2016. In total, 3,227 subjects were enrolled in the study.

Results

The patients followed at the primary care clinics were relatively young, with a mean age of 61.4±11.7 years, and had a relatively short duration of diabetes (mean duration, 7.6±6.5 years). Approximately 14% of subjects had diabetic microvascular complications. However, the patients treated at the primary care clinics had suboptimal control of hemoglobin A1c levels, blood pressure, and serum lipid levels, along with a metabolic target achievement rate of 5.9% according to the Korean Diabetes Association guidelines. The screening rates for diabetic nephropathy, retinopathy, and neuropathy within the past 12 months were 28.4%, 23.3%, and 13.3%, respectively.

Conclusion

The overall status of diabetes management, including the frequency of screening for microvascular complications, was suboptimal in the primary care clinics. More efforts should be made and more resources need to be allocated for primary care physicians to promote adequate healthcare delivery, which would result in stricter diabetes control and improved management of diabetic complications.

Citations

Citations to this article as recorded by  
  • Evidence of Overlapping Roles Between Clinics and Hospitals in Primary Care
    Boram Sim, Jihye Shin, Hyun Woo Kim, Jin Yong Lee, Min-Woo Jo
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3
    Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim, Jong Chul Won, Woo Je Lee, Min Ju Kang, Ju Young Yuh, Li Ying Du, Hyojin Lim, Kyu Jeung Ahn
    Diabetes, Obesity and Metabolism.2025; 27(12): 7110.     CrossRef
  • Digital Healthcare and Diabetic Retinopathy: Patient Experience Innovation and Support for Diabetes Care
    Sang Jun Park
    The Journal of Korean Diabetes.2025; 26(4): 208.     CrossRef
  • Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
    Li-xin Guo, Lian-wei Wang, De-zeng Tian, Feng-mei Xu, Wei Huang, Xiao-hong Wu, Wei Zhu, Jun-Qiu Chen, Xin Zheng, Hai-Yan Zhou, Hong-Mei Li, Zhong-Chen He, Wen-Bo Wang, Li-Zhen Ma, Jun-Ting Duan
    Diabetes Therapy.2024; 15(11): 2351.     CrossRef
  • Analytical techniques for determination of metformin-thiazolidinediones combination antidiabetic drug
    Imad Osman Abu Reid, Sayda Mohamed Osman, Somia Mohammed Bakheet
    Journal of Pharmacy and Allied Medicine.2024; 2(2): 82.     CrossRef
  • Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
    Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee
    Endocrinology and Metabolism.2023; 38(5): 525.     CrossRef
  • Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
    Ji Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2023; 47(6): 837.     CrossRef
  • Effectiveness of quality of care for patients with type 2 diabetes in China: findings from the Shanghai Integration Model (SIM)
    Chun Cai, Yuexing Liu, Yanyun Li, Yan Shi, Haidong Zou, Yuqian Bao, Yun Shen, Xin Cui, Chen Fu, Weiping Jia
    Frontiers of Medicine.2022; 16(1): 126.     CrossRef
  • Comparison of Health Outcomes by Care Provider Type for Newly Diagnosed Mild Type 2 Diabetes Patients in South Korea: A Retrospective Cohort Study
    Hee-Chung Kang, Jae-Seok Hong
    Healthcare.2022; 10(2): 334.     CrossRef
  • Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
    Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
    The Journal of Korean Diabetes.2022; 23(1): 64.     CrossRef
  • Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia
    Lili Legiawati, Kusmarinah Bramono, Wresti Indriatmi, Em Yunir, Aditya Indra Pratama
    Current Diabetes Reviews.2022;[Epub]     CrossRef
  • Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital
    Hyunah Kim, Da Young Jung, Seung-Hwan Lee, Jae-Hyoung Cho, Hyeon Woo Yim, Hun-Sung Kim
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
    Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Effects of Diabetes Quality Assessment on Diabetes Management Behaviors Based on a Nationwide Survey
    Chang Kyun Choi, Jungho Yang, Ji-An Jeong, Min-Ho Shin
    International Journal of Environmental Research and Public Health.2022; 19(23): 15781.     CrossRef
  • The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting
    Firas Farisi Alkaff, Fauzan Illavi, Sovia Salamah, Wiwit Setiyawati, Ristra Ramadhani, Elly Purwantini, Dicky L. Tahapary
    Journal of Primary Care & Community Health.2021;[Epub]     CrossRef
  • Questionnaire-based Survey of Demographic and Clinical Characteristics, Health Behaviors, and Mental Health of Young Korean Adults with Early-Onset Diabetes
    Ji In Park, Hyunjeong Baek, Sang-Wook Kim, Ji Yun Jeong, Kee-Ho Song, Ji Hee Yu, Il Sung Nam-Goong, Eun-Hee Cho
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study
    Min-Kyung Lee, Bongsung Kim, Kyungdo Han, Jae-Hyuk Lee, Minhee Kim, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon, Young-Jung Roh
    Diabetes Care.2021; 44(10): 2419.     CrossRef
  • Challenges in the Management of Diabetes in Primary Care
    Yeon Kyung Lee
    The Journal of Korean Diabetes.2020; 21(3): 161.     CrossRef
  • Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea
    Sung-Youn Chun, Dong Wook Kim, Sang Ah Lee, Su Jung Lee, Jung Hyun Chang, Yoon Jung Choi, Seong Woo Kim, Sun Ok Song
    Diabetes & Metabolism Journal.2020; 44(6): 897.     CrossRef
  • Comprehensive Efforts Are Needed to Improve the Quality of Primary Diabetes Care in Korea
    Chan-Hee Jung
    Endocrinology and Metabolism.2019; 34(3): 265.     CrossRef
Close layer
Clinical Study
Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data
Ji Hong You, Sun Ok Song, Se Hee Park, Kyoung Hye Park, Joo Young Nam, Dong Wook Kim, Hyun Min Kim, Dong-Jun Kim, Yong-ho Lee, Byung-Wan Lee
Endocrinol Metab. 2019;34(3):275-281.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.275
  • 10,971 View
  • 118 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hyperglycemic crisis is a metabolic emergency associated with diabetes mellitus. However, accurate epidemiologic information on cases of hyperglycemic crisis in Korea remains scarce. We evaluated trends in hyperglycemic crisis hospitalizations and in- and out-of-hospital mortality in Korea. We also predicted future trends.

Methods

We extracted claims data with hyperglycemic crisis as the principal diagnosis from the National Health Insurance Service database in Korea from January 2004 to December 2013. We investigated the numbers of claims with hyperglycemic crisis and identified trends in hyperglycemic crisis based on those claims data. We predicted future trends by statistical estimation.

Results

The total annual number of claims of hyperglycemic crisis increased from 2,674 in 2004 to 5,540 in 2013. Statistical analysis revealed an increasing trend in hyperglycemic crisis hospitalizations (P for trend <0.01). In contrast, the hospitalization rate per 1,000 diabetes cases showed a decreasing trend (P for trend <0.01) during this period. The mortality rate per 1,000 diabetes cases also showed a decreasing trend (P for trend <0.0001). However, no distinct linear trend in the case-related fatality rate at <60 days over the last decade was observed. The predicted number of annual claims of hyperglycemic crisis will increase by 2030.

Conclusion

The number of hyperglycemic crisis hospitalizations in Korea increased in the last decade, although the hospitalization rate per 1,000 diabetes cases and mortality rate decreased. Also, the predicted number of annual claims will increase in the future. Thus, it is necessary to establish long-term healthcare policies to prevent hyperglycemic crisis.

Citations

Citations to this article as recorded by  
  • Trends in admissions for hyperglycaemic emergencies and associated clinical factors in adults with type 2 diabetes in Singapore, 2013–2022
    Gerald Gui Ren Sng, Gek Hsiang Lim, Kristy Jia Yi Tian, Yong Mong Bee, Ming Ming Teh
    Diabetic Medicine.2026;[Epub]     CrossRef
  • Enhancing outcome prediction by applying the 2019 WHO DM classification to adults with hyperglycemic crises: A single-center cohort in Thailand
    Chatchon Kaewkrasaesin, Weerapat Kositanurit, Phawinpon Chotwanvirat, Nitchakarn Laichuthai
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(4): 103012.     CrossRef
  • Prevalence of hyperglycaemic crisis among diabetes mellitus patients in Ethiopia, systematic review and meta-analysis
    A Getie, T Ayenew, G Yilak, M Gedfew, BT Amlak, A Wondmieneh, M Bimerew
    Journal of Endocrinology, Metabolism and Diabetes of South Africa.2024; 29(2): 61.     CrossRef
  • Obesity and 30-day case fatality after hyperglycemic crisis hospitalizations in Korea: a national cohort study
    Hojun Yoon, Hyun Ho Choi, Giwoong Choi, Sun Ok Song, Kyoung Hwa Ha, Dae Jung Kim
    Cardiovascular Prevention and Pharmacotherapy.2023; 5(3): 74.     CrossRef
  • Interpreting global trends in type 2 diabetes complications and mortality
    Mohammed K. Ali, Jonathan Pearson-Stuttard, Elizabeth Selvin, Edward W. Gregg
    Diabetologia.2022; 65(1): 3.     CrossRef
  • Comparison of the clinical characteristics and outcomes of pediatric patients with and without diabetic ketoacidosis at the time of type 1 diabetes diagnosis
    Young-Jun Seo, Chang Dae Kum, Jung Gi Rho, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang
    Annals of Pediatric Endocrinology & Metabolism.2022; 27(2): 126.     CrossRef
  • Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis
    Mohsen S. Eledrisi, Haifaa Alkabbani, Malk Aboawon, Aya Ali, Imad Alabdulrazzak, Maab Elhaj, Ashraf Ahmed, Hazim Alqahwachi, Joanne Daghfal, Salem A. Beshyah, Rayaz A. Malik
    Diabetes Research and Clinical Practice.2022; 192: 110041.     CrossRef
  • Hyperglycemic Crisis Characteristics and Outcome of Care in Adult Patients without and with a History of Diabetes in Tigrai, Ethiopia: Comparative Study
    Getachew Gebremedhin, Fikre Enqueselassie, Helen Yifter, Negussie Deyessa
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 547.     CrossRef
  • Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea
    Min Jeong Han, Jun Ho Heo
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 783.     CrossRef
  • Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports
    Na-young Kim, Eunyeong Ha, Jun Sung Moon, Yong-Hoon Lee, Eun Young Choi
    Diabetes & Metabolism Journal.2020; 44(2): 349.     CrossRef
  • Letter: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
    Jang Won Son
    Endocrinology and Metabolism.2019; 34(4): 422.     CrossRef
  • Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
    Ji Hong You, Sun Ok Song
    Endocrinology and Metabolism.2019; 34(4): 424.     CrossRef
Close layer
Obesity and Metabolism
Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
Namki Hong, Yong-ho Lee, Kenichi Tsujita, Jorge A. Gonzalez, Christopher M. Kramer, Tomas Kovarnik, George N. Kouvelos, Hiromichi Suzuki, Kyungdo Han, Chan Joo Lee, Sung Ha Park, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
Endocrinol Metab. 2018;33(2):219-227.   Published online May 4, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.219
  • 10,388 View
  • 170 Download
  • 24 Web of Science
  • 25 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine the differential effect of ezetimibe on MACEs when added to statins according to the presence of diabetes.

Methods

Randomized clinical trials with a sample size of at least 50 participants and at least 24 weeks of follow-up that compared ezetimibe-statin combination therapy with a statin- or placebo-controlled arm and reported at least one MACE, stratified by diabetes status, were included in the meta-analysis and meta-regression.

Results

A total of seven trials with 28,191 enrolled patients (mean age, 63.6 years; 75.1% men; 7,298 with diabetes [25.9%]; mean follow-up, 5 years) were analysed. MACEs stratified by diabetes were obtained from the published data (two trials) or through direct contact (five trials). No significant heterogeneity was observed among studies (I2=14.7%, P=0.293). Ezetimibe was associated with a greater reduction of MACE risk in subjects with diabetes than in those without diabetes (pooled relative risk, 0.84 vs. 0.93; Pheterogeneity=0.012). In the meta-regression analysis, the presence of diabetes was associated with a greater reduction of MACE risk when ezetimibe was added to statins (β=0.87, P=0.038).

Conclusion

Ezetimibe-statin combination therapy was associated with greater cardiovascular benefits in patients with diabetes than in those without diabetes. Our findings suggest that ezetimibe-statin combination therapy might be a useful strategy in patients with diabetes at a residual risk of MACEs.

Citations

Citations to this article as recorded by  
  • Cardiovascular outcomes and adverse drug reactions associated with the use of ezetimibe in combination with a statin in diabetes mellitus patients with higher risk for myocardial infarction: a meta-analysis
    Yan Zhou, Ji Jin
    BMC Cardiovascular Disorders.2026;[Epub]     CrossRef
  • Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis
    Maciej Banach, Vikash Jaiswal, Song Peng Ang, Aanchal Sawhney, Novonil Deb, Pierre Amarenco, Dan Gaita, Zeljko Reiner, Ivan Pećin, Carl J. Lavie, Peter E. Penson, Peter P. Toth
    Mayo Clinic Proceedings.2025; 100(12): 2152.     CrossRef
  • Efficacy and Safety of Moderate-Intensity Statin and Ezetimibe Combination Therapy Versus High-Intensity Statin Monotherapy in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Farah Yasmin, Abdul Moeed, Muhammad Umar, Farwa Zaidi, Maryam Sarwar Khan, M Chadi Alraies
    Journal of Lipid and Atherosclerosis.2025; 14(2): 145.     CrossRef
  • 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
    Shinae Kang, Seon Mee Kang, Jong Han Choi, Seung-Hyun Ko, Bo Kyung Koo, Hyuk-Sang Kwon, Mi Kyung Kim, Sang Yong Kim, Soo-Kyung Kim, Young-eun Kim, Eun Sook Kim, Jae Hyeon Kim, Chong Hwa Kim, Ji Min Kim, Hae Jin Kim, Min Kyong Moon, Sun Joon Moon, Jun Sung
    Diabetes & Metabolism Journal.2025; 49(4): 582.     CrossRef
  • Real-World Effectiveness of Rosuvastatin–Ezetimibe Single Pill (Rovazet®) in Korean Dyslipidemia Patients
    Hack-Lyoung Kim, Hyun Sung Joh, Sang-Hyun Kim, Myung-A Kim
    Journal of Clinical Medicine.2025; 14(15): 5480.     CrossRef
  • Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study
    Wookjin Yang, Yeong-Bae Lee, Eung-Gyu Kim, Han-Jin Cho, Sungwook Yu, Joon-Tae Kim, Jong Wook Shin, Soo Joo Lee, Beom Joon Kim, Ji Man Hong, Seong-Ho Koh, Sang Joon An, A-Hyun Cho, Jin-Man Jung, Hyun-Ji Cho, Chulho Kim, Eung-Joon Lee, Jeong-Min Kim, Seung-
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Multifunctional nanoparticle-mediated combining therapy for human diseases
    Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, George Frimpong Boafo, Kosheli Thapa Magar, Yanmin Ju, Wei He
    Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
  • Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus
    Ji Hye Han, Kyong Hye Joung, Jun Choul Lee, Ok Soon Kim, Sorim Choung, Ji Min Kim, Yea Eun Kang, Hyon-Seung Yi, Ju Hee Lee, Bon Jeong Ku, Hyun Jin Kim
    Diabetes & Metabolism Journal.2024; 48(1): 112.     CrossRef
  • Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus
    Eun Roh
    Diabetes & Metabolism Journal.2024; 48(1): 55.     CrossRef
  • Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
    Il Rae Park, Jun Sung Moon
    Diabetes & Metabolism Journal.2024; 48(3): 387.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
    Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang
    Diabetes & Metabolism Journal.2024; 48(4): 546.     CrossRef
  • Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
    Kenichi Tsujita, Koutaro Yokote, Junya Ako, Ryohei Tanigawa, Sachiko Tajima, Hideki Suganami
    Journal of Atherosclerosis and Thrombosis.2023; 30(11): 1580.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
    Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Nan Hee Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, YoonJu Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae J
    Diabetes & Metabolism Journal.2023; 47(5): 575.     CrossRef
  • Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
    Yongin Cho, Hyungjin Rhee, Young-eun Kim, Minyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Jin-Young Choi, Yong-ho Lee
    BMC Medicine.2022;[Epub]     CrossRef
  • RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus
    Banshi Saboo, Sanjay Agarwal, Brij Mohan Makkar, Rajeev Chawla, Sujoy Ghosh, Vijay Viswanathan, Sunil Gupta, Ch. Vasanth Kumar, Anuj Maheshwari, L. Sreenivasamurthy, Rakesh Kumar Sahay, Sanjay Reddy, Shalini Jaggi, Jugal Kishor Sharma, Vijay Panikar, Anan
    International Journal of Diabetes in Developing Countries.2022; 42(1): 3.     CrossRef
  • Ezetimibe and diabetes mellitus:a new strategy for lowering cholesterol
    V.A. Serhiyenko, A.A. Serhiyenko
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(5): 302.     CrossRef
  • 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
    Kyu Yeon Hur, Min Kyong Moon, Jong Suk Park, Soo-Kyung Kim, Seung-Hwan Lee, Jae-Seung Yun, Jong Ha Baek, Junghyun Noh, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Ye Seul Yang, Jang Won Son, Jong Han Choi, Kee Ho Song, Nam Hoon Kim, Sang Yong Kim, Jin Wha Kim,
    Diabetes & Metabolism Journal.2021; 45(4): 461.     CrossRef
  • Combination of Statin and Ezetimibe versus Statin Monotherapy on Cardiovascular Disease and Type 2 Diabetes Incidence among Adults with Impaired Fasting Glucose: a Propensity-Matched Nationwide Cohort Study
    You-Bin Lee, Bongsung Kim, Kyungdo Han, Jung A Kim, Eun Roh, So-hyeon Hong, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo
    Journal of Lipid and Atherosclerosis.2021; 10(3): 303.     CrossRef
  • PCSK9 inhibitors and cardiovascular outcomes
    Daniel Steffens, Peter Bramlage, Céline Scheeff, Mario Kasner, Adel Hassanein, Julian Friebel, Ursula Rauch-Kröhnert
    Expert Opinion on Biological Therapy.2020; 20(1): 35.     CrossRef
  • Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis
    Jaehyun Bae, Namki Hong, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee
    Journal of Clinical Medicine.2020; 9(3): 798.     CrossRef
  • Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
    Yongin Cho, Ryeong-Hyeon Kim, Hyunki Park, Hye Jin Wang, Hyangkyu Lee, Eun Seok Kang
    Biomedicines.2020; 8(11): 512.     CrossRef
  • Future perspectives of the pharmacological management of diabetic dyslipidemia
    Angelo Maria Patti, Rosaria Vincenza Giglio, Nikolaos Papanas, Manfredi Rizzo, Ali A. Rizvi
    Expert Review of Clinical Pharmacology.2019; 12(2): 129.     CrossRef
  • Diabetes and Vascular Disease: Is It All About Glycemia?
    Alessandra Vecchié, Fabrizio Montecucco, Federico Carbone, Franco Dallegri, Aldo Bonaventura
    Current Pharmaceutical Design.2019; 25(29): 3112.     CrossRef
  • Triennial Report ofEndocrinology and Metabolism, 2015 to 2017
    Eun-Jung Rhee, Hey Yeon Jang, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 195.     CrossRef
  • Guidelines, Clinical Evidence, and Real-Life Practice: How to Find Your Way in Managing Hypercholesterolaemia
    Janet Fricker
    EMJ Cardiology.2018; : 38.     CrossRef
Close layer
Miscellaneous
Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
Ji-Yeon Lee, Namki Hong, Hye Ryun Kim, Byung Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee
Endocrinol Metab. 2018;33(1):97-104.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.97
  • 8,070 View
  • 51 Download
  • 10 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

A recent animal study showed that parathyroid hormone-related peptide (PTHrP) is associated with cancer cachexia by promoting adipose tissue browning, and we previously demonstrated that PTHrP predicts weight loss (WL) in patients with cancer. In this study, we investigated whether prediction of WL by PTHrP is influenced by clinical factors such as serum albumin, corrected calcium levels, cancer stage, and performance status (PS).

Methods

A cohort of 219 patients with cancer whose PTHrP level was measured was enrolled and followed for body weight (BW) changes. Subjects were divided into two groups by serum albumin (cutoff value, 3.7 g/dL), corrected calcium (cutoff value, 10.5 mg/dL), cancer stage (stage 1 to 3 or 4), or PS (Eastern Cooperative Oncology Group 0 to 1 or 2 to 4), respectively. Clinically significant WL was defined as either percent of BW change (% BW) <−5% or % BW <−2% plus body mass index (BMI) <20 kg/m2.

Results

After a median follow-up of 327 days, 74 patients (33.8%) experienced clinically significant WL. A positive PTHrP level was associated with a 2-fold increased risk of WL after adjusting for age, baseline BMI, serum albumin, corrected calcium level, cancer stage, and PS. The effect of PTHrP on WL remained significant in patients with low serum albumin, stage 4 cancer, and good PS. Regardless of calcium level, the effect of PTHrP on WL was maintained, although there was an additive effect of higher calcium and PTHrP levels.

Conclusion

Early recognition of patients with advanced cancer who are PTHrP positive with hypercalcemia or hypoalbuminemia is needed for their clinical management.

Citations

Citations to this article as recorded by  
  • Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
    Salvatore Cortellino, Margherita D'Angelo, Massimiliano Quintiliani, Antonio Giordano
    Journal of Cellular Physiology.2025;[Epub]     CrossRef
  • Targeting of HIF2-driven cachexia in kidney cancer
    Muhannad Abu-Remaileh, Laura A. Stransky, Nikita Bhalerao, Nitin H. Shirole, Qinqin Jiang, Eddy Saad, Marc Machaalani, Sean M. Vigeant, Hilina Woldemichael, Charles Xu, Jing Lu, Hairong Wei, Zhihong Liu, William Sun, Kei Enomoto, Toni K. Choueiri, Jason R
    Nature Medicine.2025;[Epub]     CrossRef
  • Can Patients with Electrolyte Disturbances Be Safely and Effectively Treated in a Hospital-at-Home, Telemedicine-Controlled Environment? A Retrospective Analysis of 267 Patients
    Cohn May, Gueron Or, Segal Gad, Zubli Daniel, Hakim Hila, Fizdel Boris, Liber Pninit, Amir Hadar, Barkai Galia
    Journal of Clinical Medicine.2024; 13(5): 1409.     CrossRef
  • Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting
    Britt-Marie Iresjö, Serkan Kir, Kent Lundholm
    Translational Oncology.2023; 36: 101752.     CrossRef
  • Development and Characterization of a Cancer Cachexia Rat Model Transplanted with Cells of the Rat Lung Adenocarcinoma Cell Line Sato Lung Cancer (SLC)
    Eiji Kasumi, Miku Chiba, Yoshie Kuzumaki, Hiroyuki Kuzuoka, Norifumi Sato, Banyu Takahashi
    Biomedicines.2023; 11(10): 2824.     CrossRef
  • Role of Parathyroid Hormone and Parathyroid Hormone-Related Protein in Protein-Energy Malnutrition
    Praopilad Srisuwarn, Sinee Disthabanchong
    Frontiers in Bioscience-Landmark.2023;[Epub]     CrossRef
  • Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia
    Bahar Zehra Camurdanoglu Weber, Samet Agca, Aylin Domaniku, Sevval Nur Bilgic, Dilsad H. Arabaci, Serkan Kir
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(3): 1582.     CrossRef
  • Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
    Bahar Zehra Camurdanoglu Weber, Dilsad H. Arabaci, Serkan Kir
    Frontiers in Oncology.2022;[Epub]     CrossRef
Close layer
Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
Endocrinol Metab. 2017;32(2):274-280.   Published online June 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.274
  • 11,094 View
  • 254 Download
  • 14 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   
Background

Although the beneficial effects of statin treatment in dyslipidemia and atherosclerosis have been well studied, there is limited information regarding the renal effects of statins in diabetic nephropathy. We aimed to investigate whether, and which, statins affected renal function in Asian patients with diabetes.

Methods

We enrolled 484 patients with diabetes who received statin treatment for more than 12 months. We included patients treated with moderate-intensity dose statin treatment (atorvastatin 10 to 20 mg/day or rosuvastatin 5 to 10 mg/day). The primary outcome was a change in estimated glomerular filtration rate (eGFR) during the 12-month statin treatment, and rapid renal decline was defined as a >3% reduction in eGFR in a 1-year period.

Results

In both statin treatment groups, patients showed improved serum lipid levels and significantly reduced eGFRs (from 80.3 to 78.8 mL/min/1.73 m2 for atorvastatin [P=0.012], from 79.1 to 76.1 mL/min/1.73 m2 for rosuvastatin [P=0.001]). A more rapid eGFR decline was observed in the rosuvastatin group than in the atorvastatin group (48.7% vs. 38.6%, P=0.029). Multiple logistic regression analyses demonstrated more rapid renal function loss in the rosuvastatin group than in the atorvastatin group after adjustment for other confounding factors (odds ratio, 1.60; 95% confidence interval, 1.06 to 2.42).

Conclusion

These results suggest that a moderate-intensity dose of atorvastatin has fewer detrimental effects on renal function than that of rosuvastatin.

Citations

Citations to this article as recorded by  
  • The Role of Ceramides in Metabolic and Cardiovascular Diseases
    Manuel Gonzalez-Plascencia, Idalia Garza-Veloz, Virginia Flores-Morales, Margarita L. Martinez-Fierro
    Journal of Cardiovascular Development and Disease.2026; 13(1): 30.     CrossRef
  • Effect of statins and antihyperglycemics on chronic kidney disease in patients with type 2 diabetes mellitus: a retrospective cohort study with a 12-year follow-up
    Ammar Abdulrahman Jairoun, Chong Chee Ping, Baharudin Ibrahim, Dina Farhan Al Jawamis, Asma Khaled Al Jaberi, Tasnim Dawoud, Khuloud Jamal Mohammed, Faris El-Dahiyat, Moyad Shahwan
    Journal of Pharmaceutical Policy and Practice.2025;[Epub]     CrossRef
  • Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions
    Daniele Tramontano, Simone Bini, Carlo Maiorca, Alessia Di Costanzo, Martina Carosi, Jacopo Castellese, Ina Arizaj, Daniela Commodari, Stella Covino, Giorgia Sansone, Ilenia Minicocci, Marcello Arca, Laura D’Erasmo
    Drugs.2025; 85(6): 755.     CrossRef
  • A Network Pharmacology-Based Investigation into the Mechanism of Quercetin Combined with Rosuvastatin in Delaying Diabetic Nephropathy via Inhibiting NRK-52E Cell Ferroptosis
    Meishe Gan, Zhiyuan Lin, Junxue Ma, Ning Li, Biaoliang Wu
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2681.     CrossRef
  • PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease
    Leer Bao, Xiaoguang Shi, Ying Shao
    Drugs.2025; 85(9): 1133.     CrossRef
  • Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial
    Chan Joo Lee, Woong Chol Kang, Sang Hyun Ihm, Il Suk Sohn, Jong Shin Woo, Jin Won Kim, Soon Jun Hong, Jung Hyun Choi, Jung‐Won Suh, Jae‐Bin Seo, Joon‐Hyung Doh, Jung‐Woo Son, Jae‐Hyeong Park, Ju‐Hee Lee, Young Joon Hong, Jung Ho Heo, Jinho Shin, Seok‐Min
    The Journal of Clinical Hypertension.2024; 26(3): 262.     CrossRef
  • Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin
    Shiyu Zhou, Ruixuan Chen, Jiao Liu, Zhixin Guo, Licong Su, Yanqin Li, Xiaodong Zhang, Fan Luo, Qi Gao, Yuxin Lin, Mingzhen Pang, Lisha Cao, Xin Xu, Sheng Nie
    Annals of Internal Medicine.2024; 177(12): 1641.     CrossRef
  • Anti-hyperglycemic, anti-hyperlipidemic, and anti-inflammatory effect of the drug Guggulutiktaka ghrita on high-fat diet-induced obese rats
    Samreen M. Sheik, Pugazhandhi Bakthavatchalam, Revathi P. Shenoy, Basavaraj S. Hadapad, Deepak Nayak M, Monalisa Biswas, Varashree Bolar Suryakanth
    Journal of Ayurveda and Integrative Medicine.2022; 13(3): 100583.     CrossRef
  • The challenge of reducing residual cardiovascular risk in patients with chronic kidney disease
    Stefan Mark Nidorf
    European Heart Journal.2022; 43(46): 4845.     CrossRef
  • Diabetic Kidney Disease in Older People with Type 2 Diabetes Mellitus: Improving Prevention and Treatment Options
    Ahmed H. Abdelhafiz
    Drugs & Aging.2020; 37(8): 567.     CrossRef
  • Intracellular Mechanism of Rosuvastatin-Induced Decrease in Mature hERG Protein Expression on Membrane
    Pan-Feng Feng, Bo Zhang, Lei Zhao, Qing Fang, Yan Liu, Jun-Nan Wang, Xue-Qi Xu, Hui Xue, Yang Li, Cai-Chuan Yan, Xin Zhao, Bao-Xin Li
    Molecular Pharmaceutics.2019; 16(4): 1477.     CrossRef
  • The problem of safety of lipid-lowering therapy
    M V. Zykov
    Kardiologiia.2019; 59(5S): 13.     CrossRef
  • Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction
    Titus WL Lau, Kevin E.K. Tan, Jason C.J. Choo, Tsun‐Gun Ng, Subramaniam Tavintharan, Juliana C.N. Chan
    Journal of Diabetes.2018; 10(3): 200.     CrossRef
  • Lipids: a personal view of the past decade
    Niki Katsiki, Dimitri P Mikhailidis
    Hormones.2018; 17(4): 461.     CrossRef
Close layer
Clinical Study
Obesity and Hyperglycemia in Korean Men with Klinefelter Syndrome: The Korean Endocrine Society Registry
Seung Jin Han, Kyung-Soo Kim, Wonjin Kim, Jung Hee Kim, Yong-ho Lee, Ji Sun Nam, Ji A Seo, Bu Kyung Kim, Jihyun Lee, Jin Ook Chung, Min-Hee Kim, Tae-Seo Sohn, Han Seok Choi, Seong Bin Hong, Yoon-Sok Chung
Endocrinol Metab. 2016;31(4):598-603.   Published online December 20, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.4.598
  • 8,339 View
  • 44 Download
  • 22 Web of Science
  • 20 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this study was to investigate the prevalence of obesity in Korean men with Klinefelter syndrome (KS) and the associated risk factors for obesity and hyperglycemia.

Methods

Data were collected retrospectively from medical records from 11 university hospitals in Korea between 1994 and 2014. Subjects aged ≥18 years with newly diagnosed KS were enrolled. The following parameters were recorded at baseline before treatment: chief complaint, height, weight, fasting glucose level, lipid panel, blood pressure, testosterone, luteinizing hormone, follicle-stimulating hormone, karyotyping patterns, and history of hypertension, diabetes, and dyslipidemia.

Results

Data were analyzed from 376 of 544 initially enrolled patients. The rate of the 47 XXY chromosomal pattern was 94.1%. The prevalence of obesity (body mass index ≥25 kg/m2) in Korean men with KS was 42.6%. The testosterone level was an independent risk factor for obesity and hyperglycemia.

Conclusion

Obesity is common in Korean men with KS. Hypogonadism in patients with KS was associated with obesity and hyperglycemia.

Citations

Citations to this article as recorded by  
  • Male Hypogonadism: The Korean Society of Men's Health and Aging Position Statement
    Sun Tae Ahn, Young-Sang Kim, Sung Hoon Yu, Yoon-Sok Chung
    The World Journal of Men's Health.2025; 43(3): 492.     CrossRef
  • New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities
    Angela K Lucas-Herald, Lise Aksglaede, Ida Dyhr Caspersen, S Faisal Ahmed, Francesco Carlomagno, Andrea M Isidori
    Endocrine Reviews.2025; 46(4): 447.     CrossRef
  • A dual-center study of predictive factors for sperm retrieval through microdissection testicular sperm extraction and intracytoplasmic sperm injection outcomes in men with non-mosaic Klinefelter syndrome
    Jong Hyeun Baeck, Tae Jin Kim, Tae Heon Kim, Seung-Ryeol Lee, Dong Soo Park, Hwang Kwon, Ji Eun Shin, Dong Hyeon Lee, Young Dong Yu
    Investigative and Clinical Urology.2023; 64(1): 41.     CrossRef
  • Cardiorespiratory fitness in adolescents and young adults with Klinefelter syndrome – a pilot study
    Julia Spiekermann, Kathrin Sinningen, Beatrice Hanusch, Michaela Kleber, Michael M. Schündeln, Cordula Kiewert, Heide Siggelkow, Jakob Höppner, Corinna Grasemann
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter’s Syndrome: The Role of Irisin
    Stefano Radellini, Valentina Guarnotta, Vincenzo Sciabica, Giuseppe Pizzolanti, Carla Giordano, Vito Angelo Giagulli
    International Journal of Endocrinology.2022; 2022: 1.     CrossRef
  • Metabolic and Nutritional Aspects in Paediatric Patients with Klinefelter Syndrome: A Narrative Review
    Chiara Mameli, Giulia Fiore, Arianna Sangiorgio, Marta Agostinelli, Giulia Zichichi, Gianvincenzo Zuccotti, Elvira Verduci
    Nutrients.2022; 14(10): 2107.     CrossRef
  • Klinefelter syndrome in an adolescent with severe obesity, insulin resistance, and hyperlipidemia, successfully treated with testosterone replacement therapy
    Shota Fukuhara, Jun Mori, Hisakazu Nakajima
    Clinical Pediatric Endocrinology.2021; 30(3): 127.     CrossRef
  • Glucose metabolic disorder in Klinefelter syndrome: a retrospective analysis in a single Chinese hospital and literature review
    Shixuan Liu, Tao Yuan, Shuoning Song, Shi Chen, Linjie Wang, Yong Fu, Yingyue Dong, Yan Tang, Weigang Zhao
    BMC Endocrine Disorders.2021;[Epub]     CrossRef
  • What Every Internist-Endocrinologist Should Know about Rare Genetic Syndromes in Order to Prevent Needless Diagnostics, Missed Diagnoses and Medical Complications: Five Years of ‘Internal Medicine for Rare Genetic Syndromes’
    Anna G. W. Rosenberg, Minke R. A. Pater, Karlijn Pellikaan, Kirsten Davidse, Anja A. Kattentidt-Mouravieva, Rogier Kersseboom, Anja G. Bos-Roubos, Agnies van Eeghen, José M. C. Veen, Jiske J. van der Meulen, Nina van Aalst-van Wieringen, Franciska M. E. H
    Journal of Clinical Medicine.2021; 10(22): 5457.     CrossRef
  • Klinefelter Syndrome and Diabetes
    Mark J. O’Connor, Emma A. Snyder, Frances J. Hayes
    Current Diabetes Reports.2019;[Epub]     CrossRef
  • Endocrine aspects of Klinefelter syndrome
    Adriana Herrera Lizarazo, Michelle McLoughlin, Maria G. Vogiatzi
    Current Opinion in Endocrinology, Diabetes & Obesity.2019; 26(1): 60.     CrossRef
  • Sex differences in metabolism and cardiometabolic disorders
    Karthickeyan Chella Krishnan, Margarete Mehrabian, Aldons J. Lusis
    Current Opinion in Lipidology.2018; 29(5): 404.     CrossRef
  • Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology
    Claus H Gravholt, Simon Chang, Mikkel Wallentin, Jens Fedder, Philip Moore, Anne Skakkebæk
    Endocrine Reviews.2018; 39(4): 389.     CrossRef
  • Sex differences in obesity, lipid metabolism, and inflammation—A role for the sex chromosomes?
    Temeka Zore, Maria Palafox, Karen Reue
    Molecular Metabolism.2018; 15: 35.     CrossRef
  • Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives
    Andrea Salzano, Roberta D’Assante, Liam M. Heaney, Federica Monaco, Giuseppe Rengo, Pietro Valente, Daniela Pasquali, Eduardo Bossone, Daniele Gianfrilli, Andrea Lenzi, Antonio Cittadini, Alberto M. Marra, Raffaele Napoli
    Endocrine.2018; 61(2): 194.     CrossRef
  • Síndrome de Klinefelter y riesgo cardiovascular
    A. Yamaguchi, P. Knoblovits
    Hipertensión y Riesgo Vascular.2018; 35(4): 195.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities
    Karen Reue
    Physiology & Behavior.2017; 176: 174.     CrossRef
  • Klinefelter Syndrome with Morbid Obesity Before Bariatric Surgery: A Case Report
    Parisa Janmohammadi, Gholamreza Mohammadi-Farsani, Hana Arghavani, Mahmoud Arshad, Tayebeh Mokhber
    Journal of Minimally Invasive Surgical Sciences.2017;[Epub]     CrossRef
  • Klinefelter Syndrome and Metabolic Disorder
    Ji Cheol Bae
    Endocrinology and Metabolism.2016; 31(4): 535.     CrossRef
Close layer
Clinical Study
Trends in Diabetes Incidence in the Last Decade Based on Korean National Health Insurance Claims Data
Sun Ok Song, Yong-ho Lee, Dong Wook Kim, Young Duk Song, Joo Young Nam, Kyoung Hye Park, Dae Jung Kim, Seok Won Park, Hyun Chul Lee, Byung-Wan Lee
Endocrinol Metab. 2016;31(2):292-299.   Published online June 10, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.292
  • 8,614 View
  • 57 Download
  • 38 Web of Science
  • 37 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

Epidemiological data is useful to estimate the necessary manpower and resources used for disease control and prevention of prevalent chronic diseases. We aimed to evaluate the incidence of diabetes and identify its trends based on the claims data from the National Health Insurance Service database over the last decade.

Methods

We extracted claims data on diabetes as the principal and first additional diagnoses of National Health Insurance from January 2003 to December 2012. We investigated the number of newly claimed subjects with diabetes codes, the number of claims and the demographic characteristics of this population.

Results

Total numbers of claimed cases and populations with diabetes continuously increased from 1,377,319 in 2003 to 2,571,067 by 2012. However, the annual number of newly claimed diabetic subjects decreased in the last decade. The total number of new claim patients with diabetes codes decreased as 30.9% over 2005 to 2009. Since 2009, the incidence of new diabetes claim patients has not experienced significant change. The 9-year average incidence rate was 0.98% and 1.01% in men and women, respectively. The data showed an increasing proportion of new diabetic subjects of younger age (<60 years) combined with a sharply decreasing proportion of subjects of older age (≥60 years).

Conclusion

There were increasing numbers of newly claimed subjects with diabetes codes of younger age over the last 10 years. This increasing number of diabetic patients will require management throughout their life courses because Korea is rapidly becoming an aging society.

Citations

Citations to this article as recorded by  
  • Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
    Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
    Intestinal Research.2025; 23(2): 129.     CrossRef
  • Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Ji Hong You, Kang Ju Son, Kyoung Sook Park, Byung-Wan Lee, Sun Ok Song
    Diabetology.2025; 6(12): 145.     CrossRef
  • Changing landscape of diabetes in Asia – What are the unmet needs?
    Andrea OY Luk
    Journal of Diabetes Investigation.2024; 15(4): 402.     CrossRef
  • High level of gamma-glutamyltransferase is a possible risk factor for psoriasis: A nationwide population-based cohort study
    Jongwook Oh, Kyungdo Han, Jee Yun Doh, Heon Yung Gee, Ji Hyun Lee
    Indian Journal of Dermatology, Venereology and Leprology.2024; 91: 23.     CrossRef
  • Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
    Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
    Intestinal Research.2023; 21(2): 252.     CrossRef
  • The role of nutritional status in the relationship between diabetes and health-related quality of life
    Sohyun Park, Sukyoung Jung, Hyunsook Yoon
    Nutrition Research and Practice.2022; 16(4): 505.     CrossRef
  • Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study
    Xinge Zhang, Hongjiang Wu, Baoqi Fan, Mai Shi, Eric S. H. Lau, Aimin Yang, Elaine Chow, Alice P. S. Kong, Juliana C. N. Chan, Ronald C. W. Ma, Andrea O. Y. Luk, Claudia Langenberg
    PLOS Medicine.2022; 19(7): e1004045.     CrossRef
  • Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study
    Hyun Ho Choi, Giwoong Choi, Hojun Yoon, Kyoung Hwa Ha, Dae Jung Kim
    Diabetes & Metabolism Journal.2022; 46(5): 803.     CrossRef
  • Association between Age-Related Macular Degeneration and the Risk of Diabetes Mellitus: A Nationwide Cohort Study
    Wonyoung Jung, Je Moon Yoon, Kyungdo Han, Bongseong Kim, Sungsoon Hwang, Dong Hui Lim, Dong Wook Shin
    Biomedicines.2022; 10(10): 2435.     CrossRef
  • Relationship between Dermatitis and Joint Replacement
    Joon Woo Jung, Minkook Son, Soo Hyun Jeong, Kwang Joong Kim, Kwang Ho Kim, Eun Joo Park
    Indian Journal of Dermatology.2022; 67(3): 312.     CrossRef
  • Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning analysis of population-based 10-year prospective cohort study
    Seok-Ju Hahn, Suhyeon Kim, Young Sik Choi, Junghye Lee, Jihun Kang
    eBioMedicine.2022; 86: 104383.     CrossRef
  • A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized Controlled Trial
    Min-Kyung Lee, Da Young Lee, Hong-Yup Ahn, Cheol-Young Park
    JMIR mHealth and uHealth.2021; 9(2): e17573.     CrossRef
  • Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications
    Juyoung Kim, Seok-Jun Yoon, Min-Woo Jo, Brecht Devleesschauwer
    PLOS ONE.2021; 16(2): e0246635.     CrossRef
  • Positive association between actinic keratosis and internal malignancies: a nationwide population-based cohort study
    Young Bok Lee, Ji Hyun Lee, Yeong Ho Kim, Ji Min Seo, Dong Soo Yu, Yong Gyu Park, Kyung Do Han
    Scientific Reports.2021;[Epub]     CrossRef
  • Herpes Zoster and Subsequent Cancer Risk: A Nationwide Population-Based Cohort Study in Korea
    Miri Kim, Kyungdo Han, Seung Ah Yoo, Ji Hyun Lee
    Dermatology.2021; 237(1): 73.     CrossRef
  • Identification of herpes zoster high‐risk group using Charlson comorbidity index: A nationwide retrospective cohort study
    Soo Ick Cho, Dong Hun Lee, Young Min Park
    The Journal of Dermatology.2020; 47(1): 47.     CrossRef
  • Increased risk of Alzheimer’s disease in patients with psoriasis: a nationwide population-based cohort study
    Miri Kim, Hyo Eun Park, Si-Hyung Lee, Kyungdo Han, Ji Hyun Lee
    Scientific Reports.2020;[Epub]     CrossRef
  • The incidence rates and risk factors of Parkinson disease in patients with psoriasis: A nationwide population-based cohort study
    Ji Hyun Lee, Kyungdo Han, Heon Yung Gee
    Journal of the American Academy of Dermatology.2020; 83(6): 1688.     CrossRef
  • Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
    Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
    The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
  • Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
    Andrea O. Y. Luk, Calvin Ke, Eric S. H. Lau, Hongjiang Wu, William Goggins, Ronald C. W. Ma, Elaine Chow, Alice P. S. Kong, Wing-Yee So, Juliana C. N. Chan, Sanjay Basu
    PLOS Medicine.2020; 17(2): e1003052.     CrossRef
  • Long‐term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group
    Jihyoun Lee, Ho Hur, Jong Won Lee, Hyun Jo Youn, Kyungdo Han, Nam Won Kim, So‐Youn Jung, Zisun Kim, Ku Sang Kim, Min Hyuk Lee, Se‐Hwan Han, Sung Hoo Jung, Il Yong Chung
    Cancer.2020; 126(1): 181.     CrossRef
  • The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
    Juliana C N Chan, Lee-Ling Lim, Nicholas J Wareham, Jonathan E Shaw, Trevor J Orchard, Ping Zhang, Eric S H Lau, Björn Eliasson, Alice P S Kong, Majid Ezzati, Carlos A Aguilar-Salinas, Margaret McGill, Naomi S Levitt, Guang Ning, Wing-Yee So, Jean Adams,
    The Lancet.2020; 396(10267): 2019.     CrossRef
  • Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study
    Sunho Choe, Joonki Lee, Ji Won Park, Seung-Yong Jeong, Young Min Cho, Byung-Joo Park, Aesun Shin
    Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1120.     CrossRef
  • Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data
    Ji Hong You, Sun Ok Song, Se Hee Park, Kyoung Hye Park, Joo Young Nam, Dong Wook Kim, Hyun Min Kim, Dong-Jun Kim, Yong-ho Lee, Byung-Wan Lee
    Endocrinology and Metabolism.2019; 34(3): 275.     CrossRef
  • Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
    Ji Hong You, Sun Ok Song
    Endocrinology and Metabolism.2019; 34(4): 424.     CrossRef
  • A simple screening score to predict diabetes in cancer patients
    Ji-Su Kim, Sun-Hye Ko, Myong Ki Baeg, Kyung-Do Han
    Medicine.2019; 98(51): e18354.     CrossRef
  • Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population‐based cohort study
    Ji Hyun Lee, Hyo Jung Kim, Kyung Do Han, Ha‐Na Kim, Young Min Park, Jun Young Lee, Yong‐Gyu Park, Young Bok Lee
    The Journal of Dermatology.2019; 46(2): 95.     CrossRef
  • Effects of sarpogrelate on microvascular complications with type 2 diabetes
    Hyunju Yoo, Inwhee Park, Dae Jung Kim, Sukhyang Lee
    International Journal of Clinical Pharmacy.2019; 41(2): 563.     CrossRef
  • Presence of Metabolic Syndrome Components Is Associated with Tooth Loss in Middle-Aged Adults
    Min-Jeong Cho, Youn-Hee Choi, Hyeon Chang Kim, Jee-Seon Shim, Atsuo Amano, Ji-Young Kim, Keun-Bae Song
    Yonsei Medical Journal.2019; 60(6): 554.     CrossRef
  • Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013
    Kyeong Jin Kim, Tae Yeon Kwon, Sungwook Yu, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Sin Gon Kim, Yousung Park, Nam Hoon Kim
    Diabetes & Metabolism Journal.2018; 42(5): 394.     CrossRef
  • Cancer risk by the subtype of alopecia
    Ji Hyun Lee, Yumee Song, Kyung Do Han, Young Min Park, Jun Young Lee, Yong-Gyu Park, Young Bok Lee
    Scientific Reports.2018;[Epub]     CrossRef
  • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
    Il Yong Chung, Jihyoun Lee, Suyeon Park, Jong Won Lee, Hyun Jo Youn, Jung Hwa Hong, Ho Hur
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort: study protocol and results of the first 3 years of enrollment
    Jee-Seon Shim, Bo Mi Song, Jung Hyun Lee, Seung Won Lee, Ji Hye Park, Dong Phil Choi, Myung Ha Lee, Kyoung Hwa Ha, Dae Jung Kim, Sungha Park, Won-Woo Lee, Hyeon Chang Kim
    Epidemiology and Health.2017; 39: e2017016.     CrossRef
  • Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study)
    Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee, Byung-Wan Lee
    Journal of Diabetes Research.2017; 2017: 1.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
    Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
    Diabetes & Metabolism Journal.2017; 41(5): 377.     CrossRef
  • Current status of managing diabetes mellitus in Korea
    Kyoung Hwa Ha, Dae Jung Kim
    The Korean Journal of Internal Medicine.2016; 31(5): 845.     CrossRef
Close layer
Review Article
Adrenal gland
How to Establish Clinical Prediction Models
Yong-ho Lee, Heejung Bang, Dae Jung Kim
Endocrinol Metab. 2016;31(1):38-44.   Published online March 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.1.38
  • 16,780 View
  • 267 Download
  • 140 Web of Science
  • 135 Crossref
AbstractAbstract PDFPubReader   

A clinical prediction model can be applied to several challenging clinical scenarios: screening high-risk individuals for asymptomatic disease, predicting future events such as disease or death, and assisting medical decision-making and health education. Despite the impact of clinical prediction models on practice, prediction modeling is a complex process requiring careful statistical analyses and sound clinical judgement. Although there is no definite consensus on the best methodology for model development and validation, a few recommendations and checklists have been proposed. In this review, we summarize five steps for developing and validating a clinical prediction model: preparation for establishing clinical prediction models; dataset selection; handling variables; model generation; and model evaluation and validation. We also review several studies that detail methods for developing clinical prediction models with comparable examples from real practice. After model development and vigorous validation in relevant settings, possibly with evaluation of utility/usability and fine-tuning, good models can be ready for the use in practice. We anticipate that this framework will revitalize the use of predictive or prognostic research in endocrinology, leading to active applications in real clinical practice.

Citations

Citations to this article as recorded by  
  • Early identification of high-risk older two-wheeler riders: A dual-sample approach for 30-day mortality prediction
    Ming-Chuan Hsu, Ya-Hui Chang, Chung-Yi Li, I-Lin Hsu, Chung-Shun Wong, Ping-Ling Chen, Hon-Ping Ma
    Accident Analysis & Prevention.2026; 224: 108298.     CrossRef
  • Exploring the role of health-related quality of life measures in predictive modelling for oncology: a systematic review
    T. G. W. van der Heijden, K. M. de Ligt, N. J. Hubel, S. van der Mierden, B. Holzner, L. V. van de Poll-Franse, B. H. de Rooij
    Quality of Life Research.2025; 34(2): 305.     CrossRef
  • Development and internal validation of a nomogram for predicting recurrent respiratory tract infections in children
    Fei Xia, Xi Zhou, Yan Xiong, Chenghui Yin, Minhua Wang, Ling Li
    Respiratory Medicine.2025; 238: 107961.     CrossRef
  • Systematic review of 99 extremity bone malignancy survival prediction models
    Cheng-Yo Lai, Hung-Kuan Yen, Hao-Chen Lin, Olivier Quinten Groot, Wei-Hsin Lin, Hao-Ping Hsu
    Journal of Orthopaedics and Traumatology.2025;[Epub]     CrossRef
  • Discrimination and calibration performances of non-laboratory-based and laboratory-based cardiovascular risk predictions: a systematic review
    Yihun Mulugeta Alemu, Sisay Mulugeta Alemu, Nasser Bagheri, Kinley Wangdi, Dan Chateau
    Open Heart.2025; 12(1): e003147.     CrossRef
  • The Limitation of HLA Diversity as a Risk Factor for Pediatric-Onset Autoimmune Rheumatic Disease
    Ioannis Kalampokis, Craig S. Wong, Jihyun Ma, Lynette M. Smith, Barbara J. Masten, Devon Chabot-Richards, David S. Pisetsky
    Journal of Clinical Medicine.2025; 14(3): 916.     CrossRef
  • Developing clinical prognostic models to predict graft survival after renal transplantation: comparison of statistical and machine learning models
    Getahun Mulugeta, Temesgen Zewotir, Awoke Seyoum Tegegne, Mahteme Bekele Muleta, Leja Hamza Juhar
    BMC Medical Informatics and Decision Making.2025;[Epub]     CrossRef
  • Predictors for Emergency Admission Among Homeless Metastatic Cancer Patients and Association of Social Determinants of Health with Negative Health Outcomes
    Poolakkad S. Satheeshkumar, Stephen T. Sonis, Joel B. Epstein, Roberto Pili
    Cancers.2025; 17(7): 1121.     CrossRef
  • Modelos de predicción en trasplantes: Estado del arte y aplicaciones
    Santiago Cabas, Andrea García-López, Andrea Gómez-Montero, Luis Alejandro Anichiarico-Castillo, Juan Andrés Sarmiento-Gallego, Fernando Girón-Luque
    Revista Colombiana de Cirugía.2025;[Epub]     CrossRef
  • An artificial intelligence platform for predicting postoperative complications in metastatic spinal surgery: development and validation study
    Weihao Jiang, Juan Zhang, Weiqing Shi, Xuyong Cao, Xiongwei Zhao, Bin Zhang, Haikuan Yu, Shengjie Wang, Yong Qin, Mingxing Lei, Yuncen Cao, Boyu Zhu, Yaosheng Liu
    Journal of Big Data.2025;[Epub]     CrossRef
  • The Role of Artificial Intelligence in Preoperative Assessment, Surgical Risk Stratification, and Predictive Analytics in Anesthesiology and Critical Care
    Bryan T. Romito, John C. Alexander
    Anesthesiology Clinics.2025; 43(3): 419.     CrossRef
  • Clinical Utility and Actionability of Failure to Rescue Prediction Model for Thoracolumbar Fusion: A Focus on Variable Relevance – A Commentary on “A Predictive Model of Failure to Rescue After Thoracolumbar Fusion”
    Seyed Amirhossein Tabatabaei, Mohammad Reza Cheraghi
    Neurospine.2025; 22(2): 615.     CrossRef
  • Development and validation of a risk prediction model for abdominal aortic aneurysm: a nationwide population-based cohort study
    Hyung-jin Cho, Mi-hyeong Kim, Kyung-Jai Ko, Kang-woong Jun, Kyung-do Han, Jeong-Kye Hwang
    Scientific Reports.2025;[Epub]     CrossRef
  • Lifestyle factors and colorectal cancer prediction: A nomogram-based model
    Wooin Seo, Se Young Jung, Yeonhoon Jang, Kiheon Lee
    BMC Cancer.2025;[Epub]     CrossRef
  • Prediction model developed on the basis of meta-analysis in the field of medicine: a systematic survey and methodological summaries
    Qiuyu Yang, Ying Li, Chen Tian, Jinling Ning, Yan Ma, Bei Pan, Jinhui Tian, Long Ge
    BMC Medical Research Methodology.2025;[Epub]     CrossRef
  • Risk prediction models for renal injury in children with IgA vasculitis: a systematic review and meta-analysis
    Jianrong Liao, Xuqiong Tan, Fengbi Jiang, Lin Zhu, Ping Zhou
    Pediatric Rheumatology.2025;[Epub]     CrossRef
  • Development and validation of a clinical score to identify hospitalised patients at high risk of drug-related problems
    Kulchalee Deawjaroen, Jutatip Sillabutra, Nalinee Poolsup, Derek Stewart, Naeti Suksomboon
    Journal of Pharmaceutical Policy and Practice.2025;[Epub]     CrossRef
  • Prediction models for stunting at 2-years-old from Indonesian newborn population
    Devi Azriani, Dwi Agustian, Yenni Zuhairini, Intan Nurma Yulita, Meita Dhamayanti
    BMC Pediatrics.2025;[Epub]     CrossRef
  • Construction of a Risk Score Model for Predicting Airway Management in Maxillofacial and Neck Region Space Infections Using Inflammatory Markers
    Xijun Wang, Huan Shi, Wentao Qian, Qin Zhou, Baoli Wang, Wenhao Zhang, Hui Li, Lingyan Zheng
    Journal of Inflammation Research.2025; Volume 18: 15379.     CrossRef
  • Integrating Computational Modelling into the Ecosystem of Cochlear Implantation: Advancing Access to Diagnostics, Decision-Making, and Post-Implantation Outcomes on a Global Scale
    Tania Hanekom
    Journal of Clinical Medicine.2025; 14(22): 7929.     CrossRef
  • Aligning Research Questions with Statistical Tests: A Clinician’s Practical Framework
    U. Venkatesh, Varkey Nadakkavukaran Santhosh
    NMO Journal.2025; 19(2): 182.     CrossRef
  • Models to predict length of stay in the emergency department: a systematic literature review and appraisal
    Raheleh Mahboub Farimani, Hesam Karim, Alireza Atashi, Fariba Tohidinezhad, Kambiz Bahaadini, Ameen Abu-Hanna, Saeid Eslami
    BMC Emergency Medicine.2024;[Epub]     CrossRef
  • The MISOPRED score: Development and validation of a clinical scoring system to predict the effectiveness of Misoprostol treatment for early pregnancy loss
    Tomer Bar-Noy, Ofer Limonad, Erika Gandelsman, Alon Shrim, Hila Sharabi, Raphy Zarecki, Mordechai Hallak, Ilan Bruchim, Federico Ferrari
    PLOS ONE.2024; 19(5): e0303607.     CrossRef
  • The Brilliance, Attitude, Leadership and Materials (BALM) framework of clinical excellence: an adoptable model for sub-Saharan Africa
    Taoreed Azeez
    Academic Medicine & Surgery.2024;[Epub]     CrossRef
  • Risk prediction models for diabetic nephropathy among type 2 diabetes patients in China: a systematic review and meta-analysis
    Wenbin Xu, Yanfei Zhou, Qian Jiang, Yiqian Fang, Qian Yang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Risk Assessment Tool in Predicting the Therapeutic Outcomes of Antiseizure Medication in Adults with Epilepsy
    Rose Aniza Rusli, Mohd Makmor Bakry, Noraida Mohamed Shah, Xin Ling Loo, Stefanie Kar Yan Hung
    Therapeutics and Clinical Risk Management.2024; Volume 20: 529.     CrossRef
  • Development of an IVF prediction model for donor oocytes: a retrospective analysis of 10 877 embryo transfers
    Oisin Fitzgerald, Jade Newman, Luk Rombauts, Alex Polyakov, Georgina M Chambers
    Human Reproduction.2024; 39(10): 2274.     CrossRef
  • Ambulation recovery prediction after hip fracture surgery using the Hip Fracture Short-Term Ambulation Prediction tool
    Nath Adulkasem, Pojchong Chotiyarnwong, Ekasame Vanitcharoenkul, Aasis Unnanuntana
    Journal of Rehabilitation Medicine.2024; 56: jrm40780.     CrossRef
  • Separating Risk Prediction: Myocardial Infarction vs. Ischemic Stroke in 6.2M Screenings
    Wonyoung Jung, Sang Hyun Park, Kyungdo Han, Su-Min Jeong, In Young Cho, Kihyung Kim, Yerim Kim, Sung Eun Kim, Dong Wook Shin
    Healthcare.2024; 12(20): 2080.     CrossRef
  • Predicting mid- and late-life dementia risk in primary care: A prognostic study from a national health screening cohort
    Wonyoung Jung, Sang Hyun Park, SangYun Kim, Jinkook Lee, Junhee Park, Su-Min Jeong, Seung-Yeon Lee, Kyungdo Han, Dong Wook Shin
    Psychiatry Research.2024; 342: 116237.     CrossRef
  • A new prediction diagnosis model of incomplete Kawasaki disease based on data mining with big data
    Zhen Yang, Bo Pan, Jia Liu, Haolin Wang, Jie Tian
    Pediatric Discovery.2024;[Epub]     CrossRef
  • Development and Validation of a Prognostic Model to Predict Hearing Recovery for Patients With Chronic Otitis Media
    Fengyang Xie, Xiaoyue Zhen, Haiyuan Zhu, Yan Kou, Changle Li, Ling Guo, Li Shi, Jie Han, Xuanchen Zhou
    Ear, Nose & Throat Journal.2023; 102(7): NP327.     CrossRef
  • The reporting of prognostic prediction models for obstetric care was poor: a cross-sectional survey of 10-year publications
    Chunrong Liu, Yana Qi, Xinghui Liu, Meng Chen, Yiquan Xiong, Shiyao Huang, Kang Zou, Jing Tan, Xin Sun
    BMC Medical Research Methodology.2023;[Epub]     CrossRef
  • Severity of Illness Scores and Biomarkers for Prognosis of Patients with Coronavirus Disease 2019
    Rodrigo Cavallazzi, James Bradley, Thomas Chandler, Stephen Furmanek, Julio A. Ramirez
    Seminars in Respiratory and Critical Care Medicine.2023; 44(01): 075.     CrossRef
  • Prognostic risk factor of major salivary gland carcinomas and survival prediction model based on random survival forests
    Yufan Chen, Guoli Li, Wenmei Jiang, Rong Cheng Nie, Honghao Deng, Yingle Chen, Hao Li, Yanfeng Chen
    Cancer Medicine.2023; 12(9): 10899.     CrossRef
  • Semantic Visualization in Functional Recovery Prediction of Intravenous Thrombolysis following Acute Ischemic Stroke in Patients by Using Biostatistics: An Exploratory Study
    Chih-Chun Hsiao, Chun-Gu Cheng, Cheng-Chueh Chen, Hung-Wen Chiu, Hui-Chen Lin, Chun-An Cheng
    Journal of Personalized Medicine.2023; 13(4): 624.     CrossRef
  • Clinical index to quantify the 1-year risk for common postpartum mental disorders at the time of delivery (PMH CAREPLAN): development and internal validation
    Simone N. Vigod, Natalie Urbach, Andrew Calzavara, Cindy-Lee Dennis, Andrea Gruneir, Brett D. Thombs, Mark Walker, Hilary K. Brown
    The British Journal of Psychiatry.2023; 223(3): 422.     CrossRef
  • Prediction of Foot Ulcers Using Artificial Intelligence for Diabetic Patients at Cairo University Hospital, Egypt
    Khadraa Mohamed Mousa, Farid Ali Mousa, Helalia Shalabi Mohamed, Manal Mohamed Elsawy
    SAGE Open Nursing.2023;[Epub]     CrossRef
  • Genetic Studies Investigating Susceptibility to Psoriatic Arthritis: A Narrative Review
    Mehreen Soomro, Ryan Hum, Anne Barton, John Bowes
    Clinical Therapeutics.2023; 45(9): 810.     CrossRef
  • Scope, design, and reporting of prediction models for antineoplastic drugs‐related adverse drug events: A systematic review of machine learning and traditional modeling
    Dan Jiang, Zaiwei Song, Yang Hu, Xinya Li, Rongsheng Zhao
    Journal of Evidence-Based Medicine.2023; 16(4): 420.     CrossRef
  • Using the Weibull Accelerated Failure Time Regression Model to Predict Time to Health Events
    Enwu Liu, Ryan Yan Liu, Karen Lim
    Applied Sciences.2023; 13(24): 13041.     CrossRef
  • Development and validation of a nomogram for predicting low birth weight among pregnant women who had antenatal care visits at Debre Markos Comprehensive and Specialized Hospital, Ethiopia
    Bezawit Melak Fente, Getayeneh Antehunegn Tesema, Temesgen Worku Gudayu, Mengstu Melkamu Asaye
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Prediction of psychosis: model development and internal validation of a personalized risk calculator
    Tae Young Lee, Wu Jeong Hwang, Nahrie S. Kim, Inkyung Park, Silvia Kyungjin Lho, Sun-Young Moon, Sanghoon Oh, Junhee Lee, Minah Kim, Choong-Wan Woo, Jun Soo Kwon
    Psychological Medicine.2022; 52(13): 2632.     CrossRef
  • Designing a Predictive Model for Colorectal Neoplasia Diagnosis Based on Clinical and Laboratory Findings in Colonoscopy Candidate Patients
    H. Ghajari, A. Sadeghi, S. Khodakarim, M. Zali, S. S. Hashemi Nazari
    Journal of Gastrointestinal Cancer.2022; 53(4): 880.     CrossRef
  • Avoiding immediate whole-body trauma CT: a prospective observational study in stable trauma patients
    Elisa Reitano, Stefano Granieri, Fabrizio Sammartano, Stefania Cimbanassi, Miriam Galati, Shailvi Gupta, Angelo Vanzulli, Osvaldo Chiara
    Updates in Surgery.2022; 74(1): 343.     CrossRef
  • Survival Estimation, Prognostic Factors Evaluation, and Prognostic Prediction Nomogram Construction of Breast Cancer Patients with Bone Metastasis in the Department of Bone and Soft Tissue Tumor: A Single Center Experience of 8 Years in Tianjin, China
    Yao Xu, Haixiao Wu, Guijun Xu, Zhuming Yin, Xin Wang, Vladimir P. Chekhonin, Karl Peltzer, Shu Li, Huiyang Li, Jin Zhang, Wenjuan Ma, Chao Zhang, Sharad Goyal
    The Breast Journal.2022; 2022: 1.     CrossRef
  • Machine Learning Model-Based Simple Clinical Information to Predict Decreased Left Atrial Appendage Flow Velocity
    Chao Li, Guanhua Dou, Yipu Ding, Ran Xin, Jing Wang, Jun Guo, Yundai Chen, Junjie Yang
    Journal of Personalized Medicine.2022; 12(3): 437.     CrossRef
  • Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
    Liela Meng, Keun-Sang Kwon, Dae Jung Kim, Yong-ho Lee, Jeehyoung Kim, Abhijit V. Kshirsagar, Heejung Bang
    Diabetes & Metabolism Journal.2022; 46(2): 273.     CrossRef
  • The Prediction of Diabetes
    Lalit Kumar, Prashant Johri
    International Journal of Reliable and Quality E-Healthcare.2022; 11(1): 1.     CrossRef
  • Endoscopic detection of esophageallow‐gradesquamous dysplasia: How to predict pathologic upgrades before treatment?
    Han Chen, Xiao Ying Zhou, Shuo Li, Liu Qin Jiang, Jie Hua, Xin Min Si, Guo Xin Zhang
    Journal of Digestive Diseases.2022; 23(4): 209.     CrossRef
  • Predicting outcomes after traumatic brain injury: A novel hospital prediction model for a patient reported outcome
    Rachel S. Morris, Juan F. Figueroa, Courtney J. Pokrzywa, Jason K. Barber, Nancy R. Temkin, Carisa Bergner, Basil S. Karam, Patrick Murphy, Lindsay D. Nelson, Purushottam Laud, Zara Cooper, Marc de Moya, Colleen Trevino, Christopher J. Tignanelli, Terri A
    The American Journal of Surgery.2022; 224(4): 1150.     CrossRef
  • Investigating factors affecting musculoskeletal disorders: Predictive models for identifying caregivers at risk
    Abdulrahman M. Khamaj, Abdulelah M. Ali, Mohd Mukhtar Alam
    Work.2022; 72(4): 1311.     CrossRef
  • A scoping review of complication prediction models in spinal surgery: An analysis of model development, validation and impact
    Toros C. Canturk, Daniel Czikk, Eugene K. Wai, Philippe Phan, Alexandra Stratton, Wojtek Michalowski, Stephen Kingwell
    North American Spine Society Journal (NASSJ).2022; 11: 100142.     CrossRef
  • Dynamic Predictive Models With Visualized Machine Learning for Assessing Chondrosarcoma Overall Survival
    Wenle Li, Gui Wang, Rilige Wu, Shengtao Dong, Haosheng Wang, Chan Xu, Bing Wang, Wanying Li, Zhaohui Hu, Qi Chen, Chengliang Yin
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Prognostic Nomogram of Osteocarcinoma after Surgical Treatment
    Qiuli Wu, Canchun Yang, Haolin Yan, Zheyu Wang, Zhilei Zhang, Qiwei Wang, Renyuan Huang, Xumin Hu, Bo Li, Xueliang Wu
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • External validation and clinical application of the predictive model for severe hypoglycemia
    Jae-Seung Yun, Kyungdo Han, Soo-Yeon Choi, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Clustering of trauma patients based on longitudinal data and the application of machine learning to predict recovery
    Kostas Stoitsas, Saurabh Bahulikar, Leonie de Munter, Mariska A. C. de Jongh, Maria A. C. Jansen, Merel M. Jung, Marijn van Wingerden, Katrijn Van Deun
    Scientific Reports.2022;[Epub]     CrossRef
  • Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium
    Sophie E. Smart, Deborah Agbedjro, Antonio F. Pardiñas, Olesya Ajnakina, Luis Alameda, Ole A. Andreassen, Thomas R.E. Barnes, Domenico Berardi, Sara Camporesi, Martine Cleusix, Philippe Conus, Benedicto Crespo-Facorro, Giuseppe D'Andrea, Arsime Demjaha, M
    Schizophrenia Research.2022; 250: 1.     CrossRef
  • Factors associated with low-compliance bladder in end-stage renal disease patients and development of a clinical prediction model for urodynamic evaluation: the DUDi score
    Teerayut Tangpaitoon, Valeerat Swatesutipun
    International Urology and Nephrology.2022; 55(1): 75.     CrossRef
  • Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness
    Juyoung Shin, Joonyub Lee, Taehoon Ko, Kanghyuck Lee, Yera Choi, Hun-Sung Kim
    Journal of Personalized Medicine.2022; 12(11): 1899.     CrossRef
  • Assessment of Simple Bedside Wound Characteristics for a Prediction Model for Diabetic Foot Ulcer Outcomes
    Clara Bender, Simon Lebech Cichosz, Louise Pape-Haugaard, Merete Hartun Jensen, Susan Bermark, Anders Christian Laursen, Ole Hejlesen
    Journal of Diabetes Science and Technology.2021; 15(5): 1161.     CrossRef
  • A Risk Score for Predicting the Incidence of Hemorrhage in Critically Ill Neonates: Development and Validation Study
    Rozeta Sokou, Daniele Piovani, Aikaterini Konstantinidi, Andreas G. Tsantes, Stavroula Parastatidou, Maria Lampridou, Georgios Ioakeimidis, Antonis Gounaris, Nicoletta Iacovidou, Anastasios G. Kriebardis, Marianna Politou, Petros Kopterides, Stefanos Bono
    Thrombosis and Haemostasis.2021; 121(02): 131.     CrossRef
  • Development and validation of a risk assessment nomogram for venous thromboembolism associated with hospitalized postoperative Chinese breast cancer patients
    Jing Li, Wan‐Min Qiang, Yan Wang, Xiao‐Yuan Wang
    Journal of Advanced Nursing.2021; 77(1): 473.     CrossRef
  • The role of behaviour problems in screening for mental ill-health in adults with intellectual disability
    F. Westlake, A. Hassiotis, G. Unwin, V. Totsika
    The European Journal of Psychiatry.2021; 35(2): 122.     CrossRef
  • Deep learning model for classifying endometrial lesions
    YunZheng Zhang, ZiHao Wang, Jin Zhang, CuiCui Wang, YuShan Wang, Hao Chen, LuHe Shan, JiaNing Huo, JiaHui Gu, Xiaoxin Ma
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Exploration and Development of a Simpler Respiratory Distress Observation Scale (modRDOS-4) as a Dyspnea Screening Tool: A Prospective Bedside Study
    Ru Xin Wong, Ho Shirlynn, Yen Sin Koh, Stella Goh Seow Lin, Daniel Quah, Qingyuan Zhuang
    Palliative Medicine Reports.2021;[Epub]     CrossRef
  • Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types
    Sarah Denzler, Diem Vuong, Marta Bogowicz, Matea Pavic, Thomas Frauenfelder, Sandra Thierstein, Eric Innocents Eboulet, Britta Maurer, Janine Schniering, Hubert Szymon Gabryś, Isabelle Schmitt-Opitz, Miklos Pless, Robert Foerster, Matthias Guckenberger, S
    The British Journal of Radiology.2021;[Epub]     CrossRef
  • An empirical analysis of dealing with patients who are lost to follow-up when developing prognostic models using a cohort design
    Jenna M. Reps, Peter Rijnbeek, Alana Cuthbert, Patrick B. Ryan, Nicole Pratt, Martijn Schuemie
    BMC Medical Informatics and Decision Making.2021;[Epub]     CrossRef
  • Predictive Value of Active Sacroiliitis in MRI for Flare Among Chinese Patients with Axial Spondyloarthritis in Remission
    Qing Zheng, Wen Liu, Yu Huang, Zhenyu Gao, Yuanhui Wu, Xiaohong Wang, Meimei Cai, Yan He, Shiju Chen, Bin Wang, Lingyu Liu, Shuqiang Chen, Hongjie Huang, Ling Zheng, Rihui Kang, Xiaohong Zeng, Jing Chen, Huaning Chen, Junmin Chen, Zhibin Li, Guixiu Shi
    Rheumatology and Therapy.2021; 8(1): 411.     CrossRef
  • Development of a model for predicting the 4-year risk of symptomatic knee osteoarthritis in China: a longitudinal cohort study
    Limin Wang, Han Lu, Hongbo Chen, Shida Jin, Mengqi Wang, Shaomei Shang
    Arthritis Research & Therapy.2021;[Epub]     CrossRef
  • Digital Communication Biomarkers of Mood and Diagnosis in Borderline Personality Disorder, Bipolar Disorder, and Healthy Control Populations
    George Gillett, Niall M. McGowan, Niclas Palmius, Amy C. Bilderbeck, Guy M. Goodwin, Kate E. A. Saunders
    Frontiers in Psychiatry.2021;[Epub]     CrossRef
  • Prediction of Multiple Organ Failure Complicated by Moderately Severe or Severe Acute Pancreatitis Based on Machine Learning: A Multicenter Cohort Study
    Fumin Xu, Xiao Chen, Chenwenya Li, Jing Liu, Qiu Qiu, Mi He, Jingjing Xiao, Zhihui Liu, Bingjun Ji, Dongfeng Chen, Kaijun Liu, Mirella Giovarelli
    Mediators of Inflammation.2021;[Epub]     CrossRef
  • Comparison of multiple statistical models for the development of clinical prediction scores to detect advanced colorectal neoplasms in asymptomatic Thai patients
    Kamonwan Soonklang, Boonying Siribumrungwong, Bunchorn Siripongpreeda, Chirayu Auewarakul
    Medicine.2021; 100(20): e26065.     CrossRef
  • European Childhood Obesity Risk Evaluation (CORE) index based on perinatal factors and maternal sociodemographic characteristics: the Feel4Diabetes-study
    Christina Mavrogianni, George Moschonis, Eva Karaglani, Greet Cardon, Violeta Iotova, Pilar De Miguel-Etayo, Esther M. González-Gil, Κaloyan Tsochev, Tsvetalina Tankova, Imre Rurik, Patrick Timpel, Emese Antal, Stavros Liatis, Konstantinos Makrilakis, Geo
    European Journal of Pediatrics.2021; 180(8): 2549.     CrossRef
  • A prognostic nomogram based on competing endogenous RNA network for clear‐cell renal cell carcinoma
    Yun Peng, Shangrong Wu, Zihan Xu, Dingkun Hou, Nan Li, Zheyu Zhang, Lili Wang, Haitao Wang
    Cancer Medicine.2021; 10(16): 5499.     CrossRef
  • Individual 5-Year Lung Cancer Risk Prediction Model in Korea Using a Nationwide Representative Database
    Yohwan Yeo, Dong Wook Shin, Kyungdo Han, Sang Hyun Park, Keun-Hye Jeon, Jungkwon Lee, Junghyun Kim, Aesun Shin
    Cancers.2021; 13(14): 3496.     CrossRef
  • Development and Validation of a Deep Learning Based Diabetes Prediction System Using a Nationwide Population-Based Cohort
    Sang Youl Rhee, Ji Min Sung, Sunhee Kim, In-Jeong Cho, Sang-Eun Lee, Hyuk-Jae Chang
    Diabetes & Metabolism Journal.2021; 45(4): 515.     CrossRef
  • A nomogram for predicting lymph node metastasis in superficial esophageal squamous cell carcinoma
    Weifeng Zhang, Han Chen, Guoxin Zhang, Guangfu Jin
    The Journal of Biomedical Research.2021; 35(5): 361.     CrossRef
  • Relationship Between Sensibility Tests and Functional Outcomes in Patients With Traumatic Upper Limb Nerve Injuries: A Systematic Review
    Liheng Chen, Emmanuel Ogalo, Chloe Haldane, Sean G. Bristol, Michael J. Berger
    Archives of Rehabilitation Research and Clinical Translation.2021; 3(4): 100159.     CrossRef
  • Personalized 5-Year Prostate Cancer Risk Prediction Model in Korea Based on Nationwide Representative Data
    Yohwan Yeo, Dong Wook Shin, Jungkwon Lee, Kyungdo Han, Sang Hyun Park, Keun Hye Jeon, Jungeun Shin, Aesun Shin, Jinsung Park
    Journal of Personalized Medicine.2021; 12(1): 2.     CrossRef
  • Utility of prediction model score: a proposed tool to standardize the performance and generalizability of clinical predictive models based on systematic review
    Jeff Ehresman, Daniel Lubelski, Zach Pennington, Bethany Hung, A. Karim Ahmed, Tej D. Azad, Kurt Lehner, James Feghali, Zorica Buser, James Harrop, Jefferson Wilson, Shekar Kurpad, Zoher Ghogawala, Daniel M. Sciubba
    Journal of Neurosurgery: Spine.2021; 34(5): 779.     CrossRef
  • Prodromal clinical, demographic, and socio-ecological correlates of asthma in adults: a 10-year statewide big data multi-domain analysis
    Jennifer N. Fishe, Jiang Bian, Zhaoyi Chen, Hui Hu, Jae Min, Francois Modave, Mattia Prosperi
    Journal of Asthma.2020; 57(11): 1155.     CrossRef
  • Clinical risk prediction with random forests for survival, longitudinal, and multivariate (RF-SLAM) data analysis
    Shannon Wongvibulsin, Katherine C. Wu, Scott L. Zeger
    BMC Medical Research Methodology.2020;[Epub]     CrossRef
  • Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review
    M. Pinart, F. Kunath, V. Lieb, I. Tsaur, B. Wullich, Stefanie Schmidt
    World Journal of Urology.2020; 38(3): 613.     CrossRef
  • Peripheral Nerve Field Stimulation for Chronic Back Pain: Therapy Outcome Predictive Factors
    Eric‐Jan van Gorp, Sam Eldabe, Konstantin V. Slavin, Philippe Rigoard, Stefaan Goossens, Dorothee Mielke, Giancarlo Barolat, Christ Declerck, Chris Gilmore, Ismaïl Gültuna, Kris C.P. Vissers, Jennifer Tinsley, Rudolf Likar, Pierre‐Philippe Luyet
    Pain Practice.2020; 20(5): 522.     CrossRef
  • Biomarker Score in Risk Prediction: Beyond Scientific Evidence and Statistical Performance
    Heejung Bang
    Diabetes & Metabolism Journal.2020; 44(2): 245.     CrossRef
  • Variable selection strategies and its importance in clinical prediction modelling
    Mohammad Ziaul Islam Chowdhury, Tanvir C Turin
    Family Medicine and Community Health.2020; 8(1): e000262.     CrossRef
  • Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn’s Disease
    Scott McHenry, Matthew A Ciorba, Parakkal Deepak
    Inflammatory Bowel Diseases.2020; 26(6): e46.     CrossRef
  • The application of unsupervised deep learning in predictive models using electronic health records
    Lei Wang, Liping Tong, Darcy Davis, Tim Arnold, Tina Esposito
    BMC Medical Research Methodology.2020;[Epub]     CrossRef
  • Development and evaluation of an osteoarthritis risk model for integration into primary care health information technology
    Jason E. Black, Amanda L. Terry, Daniel J. Lizotte
    International Journal of Medical Informatics.2020; 141: 104160.     CrossRef
  • An Individualized Prediction Model for Long-term Lung Function Trajectory and Risk of COPD in the General Population
    Wenjia Chen, Don D. Sin, J. Mark FitzGerald, Abdollah Safari, Amin Adibi, Mohsen Sadatsafavi
    Chest.2020; 157(3): 547.     CrossRef
  • Optimization of the management of pregnant women at high risk of miscarriage and premature birth
    Yu. A. Semenov, V. F. Dolgushina, M. G. Moscvicheva, V. S. Chulkov
    Rossiiskii vestnik akushera-ginekologa.2020; 20(1): 54.     CrossRef
  • Developing a triage tool for use in identifying people living with HIV who are at risk for non-retention in HIV care
    Merhawi T Gebrezgi, Kristopher P Fennie, Diana M Sheehan, Boubakari Ibrahimou, Sandra G Jones, Petra Brock, Robert A Ladner, Mary Jo Trepka
    International Journal of STD & AIDS.2020; 31(3): 244.     CrossRef
  • The impact of age and comorbidity on the postoperative outcomes after emergency surgical management of complicated intra-abdominal infections
    Carmen Payá-Llorente, Elías Martínez-López, Juan Carlos Sebastián-Tomás, Sandra Santarrufina-Martínez, Nicola de’Angelis, Aleix Martínez-Pérez
    Scientific Reports.2020;[Epub]     CrossRef
  • Precision health through prediction modelling: factors to consider before implementing a prediction model in clinical practice
    Mohammad Z. I. Chowdhury, Tanvir C. Turin
    The Journal of Primary Health Care.2020; 12(1): 3.     CrossRef
  • Demystifying artificial intelligence in pharmacy
    Scott D Nelson, Colin G Walsh, Casey A Olsen, Andrew J McLaughlin, Joseph R LeGrand, Nick Schutz, Thomas A Lasko
    American Journal of Health-System Pharmacy.2020; 77(19): 1556.     CrossRef
  • Association does not imply prediction: the accuracy of birthweight in predicting child mortality and anthropometric failure
    Akshay Swaminathan, Rockli Kim, S.V. Subramanian
    Annals of Epidemiology.2020; 50: 7.     CrossRef
  • Who's at Risk? A Prognostic Model for Severity Prediction in Pediatric Acute Pancreatitis
    Peter R. Farrell, Lindsey Hornung, Peter Farmer, Angelica W. DesPain, Esther Kim, Ryan Pearman, Beemnet Neway, Ashley Serrette, Sona Sehgal, James E. Heubi, Tom K. Lin, Jaimie D. Nathan, David S. Vitale, Maisam Abu‐El‐Haija
    Journal of Pediatric Gastroenterology and Nutrition.2020; 71(4): 536.     CrossRef
  • Biomarkers of Fabry Nephropathy: Review and Future Perspective
    Tina Levstek, Bojan Vujkovac, Katarina Trebusak Podkrajsek
    Genes.2020; 11(9): 1091.     CrossRef
  • Coledocolitiasis y pancreatitis: las dificultades de la predicción
    David Benigno Páramo Hernández
    Revista Colombiana de Gastroenterología.2020; 35(3): 266.     CrossRef
  • Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar
    Yan Li, Matthew Sperrin, Darren M Ashcroft, Tjeerd Pieter van Staa
    BMJ.2020; : m3919.     CrossRef
  • Outcome prediction with serial neuron-specific enolase and machine learning in anoxic-ischaemic disorders of consciousness
    Emily Muller, Jonathan P. Shock, Andreas Bender, Julian Kleeberger, Tobias Högen, Martin Rosenfelder, Bubacarr Bah, Alex Lopez-Rolon
    Computers in Biology and Medicine.2019; 107: 145.     CrossRef
  • Machine learning models to predict disease progression among veterans with hepatitis C virus
    Monica A. Konerman, Lauren A. Beste, Tony Van, Boang Liu, Xuefei Zhang, Ji Zhu, Sameer D. Saini, Grace L. Su, Brahmajee K. Nallamothu, George N. Ioannou, Akbar K. Waljee, Davide Bacciu
    PLOS ONE.2019; 14(1): e0208141.     CrossRef
  • A novel risk calculator to predict outcome after surgery for symptomatic spinal metastases; use of a large prospective patient database to personalise surgical management
    David Choi, Menelaos Pavlou, Rumana Omar, Mark Arts, Laurent Balabaud, Jacob Maciej Buchowski, Cody Bunger, Chun Kee Chung, Maarten Hubert Coppes, Bart Depreitere, Michael George Fehlings, Norio Kawahara, Chong-Suh Lee, YeeLing Leung, Juan Antonio Martin-
    European Journal of Cancer.2019; 107: 28.     CrossRef
  • Big Data Research in Neuro-Ophthalmology: Promises and Pitfalls
    Heather E. Moss, Charlotte E. Joslin, Daniel S. Rubin, Steven Roth
    Journal of Neuro-Ophthalmology.2019; 39(4): 480.     CrossRef
  • Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
    Yong-ho Lee, Yongin Cho, Byung-Wan Lee, Cheol-Young Park, Dae Ho Lee, Bong-Soo Cha, Eun-Jung Rhee
    Diabetes & Metabolism Journal.2019; 43(1): 31.     CrossRef
  • The use of rigorous methods was strongly warranted among prognostic prediction models for obstetric care
    Jing Tan, Yana Qi, Chunrong Liu, Yiquan Xiong, Qiao He, Guiting Zhang, Meng Chen, Guolin He, Wen Wang, Xinghui Liu, Xin Sun
    Journal of Clinical Epidemiology.2019; 115: 98.     CrossRef
  • Support Vector Machines and logistic regression to predict temporal artery biopsy outcomes
    Edsel Ing, Wanhua Su, Matthias Schonlau, Nurhan Torun
    Canadian Journal of Ophthalmology.2019; 54(1): 116.     CrossRef
  • Identifying a risk score for childhood obesity based on predictors identified in pregnant women and 1-year-old infants: An analysis of the data of the Hokkaido Study on Environment and Children’s Health
    Yasuaki Saijo, Yoshiya Ito, Eiji Yoshioka, Yukihiro Sato, Machiko Minatoya, Atsuko Araki, Chihiro Miyashita, Reiko Kishi
    Clinical Pediatric Endocrinology.2019; 28(3): 81.     CrossRef
  • Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists’ input to prevent medication-related problems
    Cathy Geeson, Li Wei, Bryony Dean Franklin
    BMJ Quality & Safety.2019; 28(8): 645.     CrossRef
  • Machine Learning Accurately Predicts Short-Term Outcomes Following Open Reduction and Internal Fixation of Ankle Fractures
    Robert K. Merrill, Rocco M. Ferrandino, Ryan Hoffman, Gene W. Shaffer, Anthony Ndu
    The Journal of Foot and Ankle Surgery.2019; 58(3): 410.     CrossRef
  • Multidimensional screening for predicting pain problems in adults: a systematic review of screening tools and validation studies
    Elke Veirman, Dimitri M. L. Van Ryckeghem, Annick De Paepe, Olivia J. Kirtley, Geert Crombez
    PAIN Reports.2019; 4(5): e775.     CrossRef
  • iHealthcare: Predictive Model Analysis Concerning Big Data Applications for Interactive Healthcare Systems †
    Md. Ataur Rahman Bhuiyan, Md. Rifat Ullah, Amit Kumar Das
    Applied Sciences.2019; 9(16): 3365.     CrossRef
  • Development of personalized mobile assistant for chronic disease patients: diabetes mellitus case study
    M.V. Kabyshev, S.V. Kovalchuk
    Procedia Computer Science.2019; 156: 123.     CrossRef
  • Validation of childhood asthma predictive tools: A systematic review
    Silvia Colicino, Daniel Munblit, Cosetta Minelli, Adnan Custovic, Paul Cullinan
    Clinical & Experimental Allergy.2019; 49(4): 410.     CrossRef
  • Predicting intradialytic hypotension using heart rate variability
    Samel Park, Wook-Joon Kim, Nam-Jun Cho, Chi-Young Choi, Nam Hun Heo, Hyo-Wook Gil, Eun Young Lee
    Scientific Reports.2019;[Epub]     CrossRef
  • Predicting treatment response using pharmacy register in migraine
    Thomas Folkmann Hansen, Mona Ameri Chalmer, Thilde Marie Haspang, Lisette Kogelman, Jes Olesen
    The Journal of Headache and Pain.2019;[Epub]     CrossRef
  • Development and Evaluation of Electronic Health Record Data-Driven Predictive Models for Pressure Ulcers
    Seul Ki Park, Hyeoun-Ae Park, Hee Hwang
    Journal of Korean Academy of Nursing.2019; 49(5): 575.     CrossRef
  • Characteristics and outcome of acute heart failure patients according to the severity of peripheral oedema
    Ahmad Shoaib, Mamas A. Mamas, Qazi S. Ahmad, Theresa M. McDonagh, Suzanna M.C. Hardman, Muhammad Rashid, Robert Butler, Simon Duckett, Duwarakan Satchithananda, James Nolan, Henry J. Dargie, Andrew L. Clark, John G.F. Cleland
    International Journal of Cardiology.2019; 285: 40.     CrossRef
  • Methodological standards for the development and evaluation of clinical prediction rules: a review of the literature
    Laura E. Cowley, Daniel M. Farewell, Sabine Maguire, Alison M. Kemp
    Diagnostic and Prognostic Research.2019;[Epub]     CrossRef
  • Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
    Mei-Di Hu, Si-Hai Chen, Yuan Liu, Ling-Hua Jia
    Bioscience Reports.2019;[Epub]     CrossRef
  • Assessing surgical difficulty in locally advanced mid–low rectal cancer: the accuracy of two MRI‐based predictive scores
    N. de'Angelis, F. Pigneur, A. Martínez‐Pérez, G. C. Vitali, F. Landi, S. A. Gómez‐Abril, M. Assalino, E. Espin, F. Ris, A. Luciani, F. Brunetti
    Colorectal Disease.2019; 21(3): 277.     CrossRef
  • External Validation of START nomogram to predict 3-Month unfavorable outcome in Chinese acute stroke patients
    BaiLi Song, XiangLiang Chen, Dan Tang, Mako Ibrahim, YuKai Liu, Linda Nyame, Teng Jiang, Wei Wang, Xiang Li, Chao Sun, Zheng Zhao, Jie Yang, JunShan Zhou, JianJun Zou
    Journal of Stroke and Cerebrovascular Diseases.2019; 28(6): 1618.     CrossRef
  • Development and Validation of the Korean Diabetes Risk Score: A 10-Year National Cohort Study
    Kyoung Hwa Ha, Yong-ho Lee, Sun Ok Song, Jae-woo Lee, Dong Wook Kim, Kyung-hee Cho, Dae Jung Kim
    Diabetes & Metabolism Journal.2018; 42(5): 402.     CrossRef
  • Clinical relevance and validity of tools to predict infant, childhood and adulthood obesity: a systematic review
    Oliver J Canfell, Robyn Littlewood, Olivia RL Wright, Jacqueline L Walker
    Public Health Nutrition.2018; 21(17): 3135.     CrossRef
  • Letter to Editor
    Laura E Cowley, Sabine A Maguire, Daniel M Farewell, Alison M Kemp
    Law, Probability and Risk.2018; 17(3): 275.     CrossRef
  • Self‐report assessment of severe periodontitis: Periodontal screening score development
    Maria Clotilde Carra, Alice Gueguen, Frédérique Thomas, Bruno Pannier, Giuseppina Caligiuri, Philippe Gabriel Steg, Marie Zins, Philippe Bouchard
    Journal of Clinical Periodontology.2018; 45(7): 818.     CrossRef
  • Predictive validity of the CriSTAL tool for short-term mortality in older people presenting at Emergency Departments: a prospective study
    Magnolia Cardona, Ebony T. Lewis, Mette R. Kristensen, Helene Skjøt-Arkil, Anette Addy Ekmann, Hanne H. Nygaard, Jonas J. Jensen, Rune O. Jensen, Jonas L. Pedersen, Robin M. Turner, Frances Garden, Hatem Alkhouri, Stephen Asha, John Mackenzie, Margaret Pe
    European Geriatric Medicine.2018; 9(6): 891.     CrossRef
  • Prediction of Drug-Related Risks Using Clinical Context Information in Longitudinal Claims Data
    Andreas D. Meid, Andreas Groll, Dirk Heider, Sarah Mächler, Jürgen-Bernhard Adler, Christian Günster, Hans-Helmut König, Walter E. Haefeli
    Value in Health.2018; 21(12): 1390.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research
    Hun-Sung Kim, Hyunah Kim, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Sun Jung Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Kun-Ho Yoon
    Endocrinology and Metabolism.2017; 32(1): 90.     CrossRef
  • Response to Comment by Ayubi and Safiri. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758
    Laura L. Ekblad, Juha O. Rinne, Pauli Puukka, Hanna Laine, Satu Ahtiluoto, Raimo Sulkava, Matti Viitanen, Antti Jula
    Diabetes Care.2017; 40(9): e136.     CrossRef
  • Encrypted prediction: A hacker's perspective
    Tara Karamlou, Daniel A. Velez, John J. Nigro
    The Journal of Thoracic and Cardiovascular Surgery.2017; 154(6): 2038.     CrossRef
  • Personalized medicine. Closing the gap between knowledge and clinical practice
    Juan-Manuel Anaya, Carolina Duarte-Rey, Juan C. Sarmiento-Monroy, David Bardey, John Castiblanco, Adriana Rojas-Villarraga
    Autoimmunity Reviews.2016; 15(8): 833.     CrossRef
  • Comparison of screening scores for diabetes and prediabetes
    Eduard Poltavskiy, Dae Jung Kim, Heejung Bang
    Diabetes Research and Clinical Practice.2016; 118: 146.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP